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TITLE: ETIOLOGY AND CLINICAL OUTCOME OF STROKE IN YOUNG 
ADULTS (18-45YEARS) ADMITTED IN A TERTIARY CARE HOSPITAL 
ABSTRACT : 
Background : Stroke  among  young  adults (18-45years)  poses  a  major  
socioeconomic  health  problem  especially  in  developing  countries. It is an 
important cause of morbidity and mortality among young adults. This study was aimed to 
evaluate the etiology, risk factors and clinical outcome of arterial ischaemic stroke in 
young adults aged 18-45 years. 
Materials and Methods: The  study  is  based  on  prospective  collection  of  data  
of  young  adults admitted  in  medical  ward  or  neurology  ward  in  a  tertiary  
care  hospital during  the  study  period  of  June, 2014 to  June, 2015. A proforma 
for each of the acute ischemic stroke patients was maintained. Data was analyzed using 
SPSS version 12. Chi-square was used. p value of <0.05 was considered to be 
significant.  
Results: In this study, there were 36 males and 14 females with a mean (SD) age of 39.4 
(9.5) years at onset of stroke. Smoking, alcohol intake and dyslipidemia were 
significantly more prevalent in the study group. An aetiological categorization of stroke 
was obtained in 39 (78%) patients and it was of unknown in the rest. Athero-thrombotic 
stroke and cardio-embolic stroke occurred in 40% and 16%, respectively. 
Hyperhomocystinemia also has a significant association with occurrence of stroke. 
Outcome assessment by using scoring scales (NIHSS and mRS at baseline and 3months), 
after a follow up of 3 months, 50% of the study group (25) were independent or only 
mildly disabled. The fatality rate observed was 2%. 
Conclusion: Ischaemic stroke in the young adult is more frequent in males. Modifiable 
risk factors – Smoking, alcohol and dyslipidemia were very common. Etiology can be 
determined in the majority and the athero-thrombotic process predominates. The 
mortality was negligible and the functional outcome is good in most of the patients.Thus, 
the knowledge of the risk factors and clinical presentation acute ischemic stroke in young 
adults can help in prevention, better understanding and therapeutic decision making in the 
disease management. 
Keywords: Young adults, Arterial Ischemic Stroke, Risk factors 
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INTRODUCTION 
Stroke  is  the  most  common  life  threatening  or  disabling  neurological  
condition. Although  it  is considered  as  disease  of  older  population, it  is  
not  infrequent  in  young  adults. Stroke  in  young  adults  poses  a  major  
socioeconomic  health  problem  especially  in  developing  countries (1). 
Stroke  is  the  third  most common  cause  of  mortality(2)  and  the  fourth 
leading  cause  of  disease  burden in the world(3).It  has an important 
contribution  towards  morbidity,  disability and mortality in both developed  
as  well  as  developing  countries. 
World  Health  Organization (WHO)  definition  of  stroke  is: “rapidly  
developing  clinical  signs  of focal  (or  global)  disturbance  of  cerebral  
function, with  symptoms  lasting  24 hours  or  longer  or  leading  to  death, 
with  no  apparent  cause  other  than  of  vascular  origin.” 
Stroke  leads  to  cut  off  of  the  oxygen  and  nutrients  supply  to  the  
cerebral  tissue  leading  to cerebral  damage (1). The  effects  of  a  stroke  
depend  on  which  part  of  the  brain  is  injured  and  how  severely  it  is  
affected. The  most  common  symptom  of  a  stroke  is  sudden  weakness  or 
numbness  of  the  face,  arm,  or  leg,  most  often  on  one  side  of  the  
body, occurring  in  90%  of  the  strokes(4). Other  symptoms  include  
confusion;  difficulty  speaking  or  understanding  speech; difficulty  seeing  
with  one  or  both  eyes;  difficulty  walking,  dizziness,  and  loss  of  balance  
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or coordination;  severe  headache  with  no  known  cause;  fainting  or  
unconsciousness.  
It  leaves  the patients  with  residual  disabilities  like  physical  dependence,  
cognitive  decline,  depression,  and seizures.  A very  severe  stroke  can  
cause  sudden  death. 
The prevalence of various risk factors in stroke in young has been analysed in 
two studies from India(5). In  a  case  control  study  of  young  stroke  
patients  of age group 15-45 years  with  age- and  sex-matched  hospital  and  
community  controls, prevalence  of  various  risk factors was studied. In  
another  study  in 1997(6),177 patients with first ever ischemic stroke (age  
group 15-45 years) were  taken  retrospectively  based  on  hospital  data,  
with  76% male  and  24% female patients. Hypertension  was  present  in 
18%  of  the  patients, whereas  diabetes  mellitus  was  present  in  7%  only. 
69%of  male  patients  were  smokers. Dyslipidaemia  in  the form  of  
elevated  cholesterol  was  present  in 17%  and  increase  in  triglycerides  
was  observed  in  42%  patients. 
A Study of Stroke among young adults in a Tertiary Hospital in North India -  
A retrospective review of case records from patients with ischemic stroke in 
the age range of 18-45 years was conducted from 2005 to 2010. Data 
regarding patients’ clinical profiles, medical histories, diagnostic test results, 
and modified Rankin Scale scores at hospital discharge were examined. 
Stroke subtyping was conducted in accordance with the Trial of Org 10172 in 
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Acute Stroke Treatment (TOAST) criteria. 440 patients in the 18-45 year age 
range were identified with stroke out of which 83.4% were male. The most 
common risk factors were hypertension (34.4%) and dyslipidemia (26.5%). 
The most common subtype of stroke was undetermined (57%), followed by 
other determined causes (17.3%). Most of the patients demonstrated good 
functional outcomes. The results highlight the needs for aggressive 
management of traditional risk factors and extensive patient work-up to 
identify stroke etiology in India(7). 
In a study on ischaemic stroke in young adults - Clinical features, risk factors 
and outcome was considered in the study done at Sri ChitraTirunal Institute of 
Medical Sciences and Technology, Trivandrum.This is a retrospective study 
done with medical records of 177 patients in a tertiary referral centre admitted 
between January 1988 and March 1994. Patients with ischaemic stroke were 
classified based on Trial on ORG 10172 in Acute Stroke Treatment (TOAST) 
criteria; out of which 25.2% patients had cardio-embolic stroke, 12.6% had 
large artery atherosclerosis and 7.5% had lacunar infarcts. Strokes due to 
other determined etiology were 11.2%. It was aimed to evaluate clinical 
features, risk factors and outcome of ischaemic stroke in young adults aged 
15-45 years. It is more frequent in young males. Hypertension, smoking, 
hyperlipidaemia and athero-thrombotic stroke were significantly more 
prevalent. These cases were followed up at mean time of 7 months, 75% of 
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the patients were independent or only mildly disabled. The mortality observed 
was very little and functional outcome was good in most of the patients(8) 
In  Helsinki  Young  Stroke  Registry(9)  which  included  1008  first  ever 
consecutive  patients  of  ischemic  stroke  in  the  age  group  of  15-49 years, 
admitted in 1994 to 2007. The etiology was classified by Trial of Org 10172 
in Acute Stroke Treatment criteria. Comparisons were done between groups 
stratified by gender and age.Hypertension,  smoking  and  dyslipidaemia  with  
high total  cholesterol  emerged  as  important  risk  factors. The prevalence of 
hypertension increased with increasing age. It was also observed that, among 
the  study population, preponderance of stroke was more among females with 
age of those <30, whereas males showed dominance with rapidly increased 
age of 44. The most frequent risk factors were dyslipidemia (60%), smoking 
(44%), and hypertension (39%). Left hemisphere infarcts were more common 
in general. The study was concluded saying that the frequency of ischemic 
stroke increases sharply at age 40. Subclinical infarcts were surprisingly 
common in the young.  
It  appears  that  the  risk  factors  for  stroke  in  Indian  population  are  not  
different  from  that of the western or Southeast Asian population. The 
traditional risk factors like hypertension, smoking  and diabetes  are  
associated  with  stroke  in  both  young  and  elderly. In  recent  years, there  
has  been increasing  economic  and  demographic  development  in  
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developing  countries  resulting  in  a  shift  from  diseases  caused  by  
poverty  towards  chronic,  non-communicable,  lifestyle-related  
diseases(10). This  happening  in  the  younger  age  group  adds  to  the  
social  and  economic  burden, and as such  these  patients  merit  special  
attention  in  diagnostic,  therapeutic,  and  preventive  care. 
A study was conducted to assess the clinical outcome in 287 consecutive 
young adults (15 to 45 years) with ischemic stroke by D. Leys MD et al.; and 
3-year outcome was also observed in young patients admitted between 1992 
and 1996 which was obtained with clinical examinations or telephone 
interviews, and data were recorded about risk factors, associated disorders, 
causes of stroke, and current treatments. In this study, young patients who 
experience ischemic strokes have a low risk of stroke recurrence and 
myocardial infarction(11). 
FIGURE 1: 
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Therefore  the  need  of  this  study  is  to  reveal  the  burden  of  stroke  in  
young  adults  in  a  tertiary  care  hospital,  the frequency  of  aetiology  of  
stroke  in  young  adults  with contributing  risk  factors and their effect on the  
clinical  outcome  of  the  patients  of  young  stroke  in  tertiary  care(12). 
Early  identification  of  risk  factors  and  implication  of  preventive  
measures  can  help  in  bringing  down  the  occurrence  of  stroke  and  
reduce the financial  and  emotional burden  in  the  family.  A dedicated  
evaluation  for  identifying  the  cause  is  needed  to  treat  and  prevent  
further  recurrences. 
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AIMS AND OBJECTIVES 
 To  study  the  aetiology  and  clinical  outcome  of  stroke  in  young  
adults (18-45years)  in  a  tertiary  care  centre. 
 To  assess  the  morbidity  and  mortality  of  the  stroke  in  young  
adults. 
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MATERIALS AND METHODOLOGY 
Type of study: Prospective and clinical study 
Place of study: PSG Hospitals, PSG  IMS&R, Coimbatore 
Duration of Study: One year (June 2014 – June 2015) 
Study Population: Patients aged (18-45 years) diagnosed  as  stroke in 
Department of  General Medicine and Neurology,  meeting  the  inclusion  
criteria  in PSG IMS &R, Coimbatore,  during the study period of 1 year June 
2014 to June 2015. Patient  sample  size  is  restricted  to  a  total  number  of  
50cases.  
INCLUSION CRITERIA: 
 Age between 18-45years 
 Patients admitted in general medical ward/neurology ward with abrupt 
onset of focal neurological deficit of vascular origin (ischaemic or 
haemorrhagic) and persisting for more than 24hrs. 
EXCLUSION CRITERIA 
 Pregnant  women  or  postpartum  women  within  30days 
 Age  less  than  18years 
 Age  more  than  45years 
 Head  trauma 
 Neuro  infections  causing  weakness 
 Venous  strokes 
 CNS  Tumours  with  weakness 
  Subdural  haemorrhage and haemorrhagic strokes 
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METHODOLOGY: 
The  study  is  based  on  prospective  collection  of  data  of  young  adults  
aged  between 18-45years  diagnosed  as stroke  who  got  admitted  in  
medical  ward  or  neurology  ward  in  a  tertiary  care  centre  where  
systematic  computer  coding  for  registry  is  used.  
Patients  admitted  at PSG  hospitals, Coimbatore diagnosed  with  stroke  
confirmed  with  imaging  at  admission  and  meeting  the  inclusion  criteria  
as  mentioned  above,  during  the  study  period  of  June, 2014 to  June, 2015  
are  taken  into  consideration  for  the  study.  A proforma  is  prepared  
which included detailed history, clinical examination and requisite 
investigations available in the hospital. After taking informed consent from 
the patient, history and risk factors attributable to the stroke are collected in 
detail. Investigations like complete hemogram, routine urine analysis, blood 
sugar, serum elecctrolytes, serum creatinine, blood urea, serum homocysteine, 
chest X-ray, electrocardiogram, CT or MRI brain were done in all patients. 
Investigations like ANA profile, APLA were done in the patients as required. 
According  to  the  imaging  done  at  the  baseline  and  risk  factors  
associated  with  the patient, the  stroke  subtypes classified accordingly by 
using classification  developed  for  Trial  of  Org  10172  in  Acute  Stroke  
Treatment (TOAST). 
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TABLE 1: 
TOAST  Classification  Of  Subtypes  Of  Acute  Ischemic  Stroke 
Large-artery atherosclerosis (embolus/thrombosis) 
Cardioembolism (high-risk/medium-risk) 
Small-vessel occlusion(lacunae) 
Stroke of other determined etiology 
 
Stroke of undetermined etiology 
a. Two or more causes identified 
b. Negative evaluation 
                     c. Incomplete evaluation 
 
Patients  are  examined  clinically in detail  and  their  severity  is  being  
assessed  by  National  Institute  of  Health  stroke  scale (NIHSS) at  baseline. 
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TABLE 2: National Institute of Health stroke scale (NIHSS)  
STROKE STROKE  SEVERITY 
0 No  stroke  symptoms 
1-4 Minor  Stroke 
5-15 Moderate  Stroke 
16-20 Moderate  to  Severe  Stroke 
21-42 Severe  Stroke 
 
To  assess  the  clinical  outcome  of  the  patients, mRS scoring is  done  at  
the  baseline  and after  3  months  and  are  correlated  accordingly. This scale 
runs from 0-6, running from perfect health without symptoms to death. 
(TABLE 3) 
SCORE SYMPTOMS 
 0  No symptoms 
 1  No significant disability. Able  to  carry  out  all  usual  
activities, despite  some  symptoms 
 2  Slight disability. Able  to  look  after  own  affairs  without  
assistance, but  unable  to  carry  out  all  previous  activities 
 3  Moderate disability. Requires  some  help, but  able  to  walk  
unassisted 
 4  Moderately severe disability. Unable  to  attend  to  own  
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bodily  needs  without  assistance,  and  unable  to  walk  
unassisted 
 5  - Severe  disability. Requires  constant  nursing  care  and  
attention, bedridden,  incontinent 
 6  -Dead 
 
The results were analysed to assess the etiology, risk factors and clinical 
outcome in the patients diagnosed with stroke. 
Statistical tools: 
The  data  collected  from  the  patients  is  tabulated  using  Microsoft  Excel.  
The data are reported as the mean +/- SD or the median, depending on their 
distribution. The differences in quantitative variables between groups were 
assessed by means of the unpaired t test. Comparison between groups was 
made by the non-parametric Mann- Whitney test. ANOVA was used to assess 
the variables. The chi square test was used to assess the difference in 
categoric variables between groups. 
Descriptive  analysis  is  done  using  chi  square  test  and  statistical analysis  
and  interpretation  of  the  data  collected  is  done  by  using  SPSS  version  
20. p value  of <0.05 using two tailed test was taken as being of significance 
for all statistical tests. All data were analysed with a statistical software 
package (SSPS version 16.0 for windows) 
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REVIEW OF LITERATURE 
History and Background: 
Stroke was first recognized by HIPPOCRATES (460 to 370 BC), father of 
medicine some 2400 years ago. Initially is was termed as apoplexy in Greek 
(meaning “struck down by violence”). 
Johann Jacob Wepfer (1620–1695), the next well renowned person in the field 
of stroke. He studied on the corpses of deceased due to apoplexy, to know the 
cause of apoplexy. He discovered that blood supply might be disrupted to the 
brain in the deceased either due to blocked arteries in few or they had been 
massive bleeding into the brain tissue(13). 
Rudolf Virchow known as father of modern pathology was the first to 
describe the mechanism of thrombo embolism as a major factor causing 
stroke. In the mid nineteenth century , he describes the term thrombosis which 
can detached to form embolus causing cardio-embolic stroke(14). 
In the year 1928, apoplexy was subcategorised based on the cause. After 
which the term cerebrovascular accident has been come into norms. Recently 
in 2011, use of this term cerebrovascular accident has been discouraged 
reasoning that the connotation of fortuitousness carried by the word accident 
insufficiently highlights the modifiability of the underlying risk factors(15), 
(16). Now it is used as cerebrovascular incident interchangeably. 
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DEFINITION AND CLASSIFICATION: 
Although more common in older adults, stroke also occurs in neonates, 
infants, children and young adults, resulting in significant morbidity and 
mortality(17). Stroke is a clinical syndrome which is classified broadly as: 
 Ischaemic strokes – These are caused by sudden occlusion of arteries 
supplying the brain, either due to thrombus at the site of occlusion or 
formed in another part of circulation causing restriction of blood 
supply to the part of brain causing cerebral infarction. It accounts for 
50-85% of all strokes worldwide(18). 
 Haemorrhagic strokes –defined as bleed which occurs within substance 
of the brain, intracerebral haemorrhage or contained within the 
subarachnoid haemorrhage(19). 
 Transient ischemic attacks (TIAs) are defined as temporary 
neurological deficit with symptoms lasting less than 24hrs and which is 
thought to be due to inadequate cerebral or ocular blood supply as a 
result of arterial or embolism associated with arterial, cardiac or 
haematological disease. It serves as a warning signal for impending 
stroke. It leaves no clinical or imaging tracing(20). 
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EPIDEMIOLOGY: 
Stroke is now considered as the second most common cause of death 
worldwide in 2011, accounting for 6.2 million deaths (~11% of the 
total)(21).There in increasing prevalence of stroke in developing countries 
from past two decades(22) whereas decreasing trend is observed in developed 
countries.  
In India, the prevalence of stroke is in increasing trend. The incidence of 
stroke increases exponentially from 30 years of age, and etiology varies by 
age. About two-thirds of strokes occur in those over the age of 65(23), (24). It 
has been observed now that the prevalence is becoming high among younger 
age group and low socioeconomic status(25) 
As there is increasing prevalence and incidence rates of stroke among older 
individuals, these is also increase in the prevalence of stroke in younger 
individuals (18-32% of all stroke cases) compared to that among the western 
countries.When considering the annual incidence rates of arterial ischemic 
stroke (AIS) in adults younger than 45 years old, incidence ranges from 3.4 to 
11.3/100,000 people per year in primarily white populations (26)(27), while 
the incidence in young black adults is as high as 22.8/100,000 people per 
year(28).Indian Council Medical Research (ICMR) estimated in 2004 there 
were 9,30,985 cases of stroke in India with 6,39,455(41%) deaths and 6.4 
million (72%) disability life adjusted years (DALY) lost(29). 
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This increase in prevalence and incidence is most likely due to rapid 
urbanisation among the villagers who migrated to urban areas, changing 
lifestyles, sedentary habits, smoking, excess alcohol intake, rising stress levels 
in life, etc(30). 
Risk factors: 
Risk factors are defined as any attribute, characteristic or exposure of an 
individual that increases the likelihood of developing a disease or injury. Risk 
factors may be further classified as modifiable or non-modifiable. 
Non modifiable risk factors: 
Risk factors like age, gender, race/ethinicity and family genetics come under 
non modifiable risk factors. 
1. Gender: Considering globally, males are affected predominantly 
regardless of age and stroke subtype. In Indian scenario, this difference 
observed is due to high prevalence of smoking and alcohol among males 
comparatively. The male : female sex ratio among affected individuals is 
7:1 in India(31)(32) 
Few etiologies are confined only to the female population. Most of the 
strokes are observed commonly among the reproductive age group due to 
pregnancy or oral contraceptive usage. Though prevalence of occurrence 
of stroke is high among males, prevalence of death is high among females 
comparatively. 
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2. Race and ethnicity: blacks are more commonly affected with stroke 
compared to whites. Lack of proper awareness, affordability and no 
insurance are few among factors due to this observed difference in 
occurrence of stroke(33)(34). 
3. Family genetics: Family members may have genetic tendency or share 
lifestyles and behavioural patterns that significantly contribute to the 
occurrence of stroke. Genetic factors for hypertension, Von Willebrand 
factors, Sickle cell disease among family may also contribute to increased 
risk of stroke. Risk of stroke further increases with a past history of stroke. 
Although heredity plays only a minor role in the pathogenesis of stroke, an 
increased risk is seen among first-degree relatives with a family history of 
stroke. The heredity factor when combined with unhealthy lifestyle leads 
to attenuated risk among the individuals.(35)(36) 
Modifiable 
 Cigarette smoking – It is one of the most important risk factor of stroke 
among young adults. Risk of stroke increases by four fold among young 
adults in smokers compared to non-smokers. The risk depends on both 
duration and dosage of exposure to smoking. Smoking more than 20 
cigarettes per day are at higher risk of developing ischemic stroke. The 
risk of stroke increases by enhancing atherogenesis, triggering cardiac 
arrhythmias and arterial thrombosis and vasospasm. It also adds to the 
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economic burden in the family and country. If associated with other risk 
factors there will be synergistic effect on risk of stroke occurrence(37).  
 Alcohol consumption–This is another modifiable and preventable risk 
factor for stroke in young adults. It differs among men and women. In 
men, binge drinking of alcohol are at higher risk of developing ischemic 
stroke than in non -alcoholics or alcoholic abstainers. Binge drinking has 
effect of raising blood pressure which further increases risk of 
stroke(38).In men, binge drinking is defined as six or more drinks 
(alcoholic beverage) in men, whereas it is four or more in women in one 
session. In women the risk increases with increase in intake of alcohol. 
Unlikely, consumption of wine has protective effect.  
 Dyslipidaemia – Atherogenic dyslipidaemia is an independent risk factor 
of stroke among young adults and also plays a role in causing higher 
prevalence of recurrent stroke. Atherogenic dyslipidemia is defined as 
higher levels of low-density lipoprotein cholesterol (LDL-C) along with 
consideration of other factors such as high triglycerides (TGL) (TGL ≥150 
mg/dL) and low high-density lipoprotein cholesterol (HDL-C) (HDL-C 
≤40 mg/dL)(39).Elevated apolipoprotein B and A1 levels arealso 
associated with young stroke. Elevated LDL and TGL levels increase the 
intimal thickness of carotid artery thereby increasing atherosclerosis.  It is 
associated with symptomatic intracranial stenosis identified by computed 
tomography (CT) imaging or magnetic resonance imaging of cerebral 
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blood vessels (MRI).They comprise a metabolic pattern that may be 
driven by insulin resistance, which ultimately leads to accelerated 
progression of atherosclerotic vascular disease(9). 
 Abdominal obesity – defined as BMI more than 30kg/sq.m. Predisposing 
mechanism to stroke in obese individuals is likely due to its effect on 
arterial hypertension associated with elevated cholesterol levels. It mainly 
plays an important contributory factor for stroke. Upper body obesity is 
more important than lower body obesity as risk factor(40).Increased waist 
hip ratio is associated with early death. People should be encouraged to 
increase daily physical activity and reduction of weight in order to lessen 
the risk of stroke.Increased physical activity also decreases platelet 
aggregation and increase insulin sensitivity(41). 
 Sedentary life style –It has been a contributory factor for occurrence of 
stroke in young individuals. Blood pressure, impaired glucose tolerance, 
insulin resistance are associated with altered lipid profile with increasing 
risk for stroke. Lifestsyle modifications like regular exercise, weight 
reduction measures and dietary modifications may help for good health 
and decrease in incidence. 
 Hypertension – It is defined as systolic blood pressure (SBP) more than 
140 mm Hg or diastolic blood pressure (DBP) more than 90 mmm Hg. It 
is considered both primary as well secondary cause of death among stroke 
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in young adults. 70% people with hypertension develop stroke. 
Hypertension increases stress and causes damage of vascular endothelium. 
This damage causes thrombi formation and ischemic lesions mainly 
affecting large extra-cranial vessels. Both elevated diastolic and systolic 
blood pressures are associated with increased concentrations of 
haemoglobin, which is a risk factor for ischaemic stroke(42)(43). Isolated 
systolic blood pressure and pulse pressures are at greater risk.  
 
In chronic hypertension, there is vessel wall thickening and luminal 
narrowing which limit the capacity of the resistance vessels for dilation. In 
acute stroke, auto-regulation may be impaired in regions surrounding an 
acute lesion and even in the hemisphere contralateral to the lesion because 
of dilation of cerebral resistance vessels in an attempt to increase blood 
flow in response to tissue ischemia and acidosis. More recently, it has 
been shown that auto-regulation is impaired rapidly (dynamic auto-
regulation) in conditions where systemic BP even is well preserved for 
controlled changes.About 10-20 mm of Hg decrease in SBP causes 
reduction of incidence of stroke of 28% in young adults(44). 
 Diabetes mellitus: Increasing prevalence of diabetes causes increases 
macro-vascular complications thereby playing one of the major risk factor 
of concern in causing stroke. It is one of the long term complication of 
stroke(45). Three factors - fasting blood glucose (FBS), glycosylated 
haemoglobin (HbA1c) and duration of diabetes have significant impact on 
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risk of stroke among young adults. FBS more than 13.4mmol/l, HbA1c 
more than 6.5% and duration of diabetes for more than 7 years. Stroke 
occurring in diabetic individuals is usually no reversible. Persons with 
both type 1 and type 2 diabetes mellitus (DM) have increased 
susceptibility affecting both large and small vessel occlusive disease. 
Diabetes increases fibrinogen and clotting factors thereby causing 
increasing platelet aggregation promoting formation of arterial 
thrombosis(46). There is 11 times higher risk of stroke in young adults 
compared to older age group. Hyperglycemia does not present with signs 
typical of stroke whereas hypoglycaemia can mimic as stroke causing 
neurological deficits. It is therefore said that prompt treatment of 
hypoglycaemia in emergency conditions in suspicion of stroke. 
 
 Oral contraceptives–risk of stroke in young women taking oral 
contraceptives is four times higher. High dose oestrogen doubles the risk 
of stroke than low dose oestrogen(47). Women with other associated 
factors like smoking, pro-thrombotic genetic variants and migraine, the 
risk increases further. High prevalence of thromboembolic stroke is seen 
in these conditions(48). Newer oral contraceptives with low levels of 
estrogen are being used to decrease the incidence of stroke in women.  
 Pregnancy : Pregnancy and puerperium - Estrogen related stroke – Risk of 
stroke is high in third trimester and 6 weeks of post-partum period (49). 
Pre-eclampsia and eclampsia play a synergistic role of nine fold increase 
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in stroke occurrence(50). Amniotic fluid embolism, postpartum 
angiopathy and postpartum cardiomyopathy can result in cardio-embolism 
or infarction due to hypotension. It may also be influenced by underlying 
haemotological or thrombotic conditions 
 Illicit drug abuse : Recreational drug abuse in young adults increases the 
susceptibility of stroke in young adults. Injectable drugs are more prone 
for embolic stroke(51). Use of certain drugs (eg, cocaine, amphetamines, 
crack) having sympathomimetic activity causing hypertension, platelet 
aggregation leading to endocarditis causing embolic stroke(52). Attimes, 
they may cause vasculitis of arteries and arterioles causing stroke. Drugs 
like heroin, opiates, cannabinoids also play a role in etiology of ischemic 
stroke. 
 Migraine headache – There is increased risk of ischemic stroke among 
young women (35-45years) with migraine headache with aura (MA).The 
risk is attenuated with concomitant use of oral contraceptives, smoking 
and blood pressure. It has a bidirectional relation where cerebral ischemia 
may induce migraine headache(53). Most commonly they have occipital 
headaches involving nearly about one third of total cases. Special concern 
are people with patent foramen suffering with MA great high risk(54). 
There present guidelines indicate that early treatment and prevention of 
migraine headache in order to reduce the frequency of MA in women. 
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 Prior stroke or TIA – increasing mortality and DALY lost seen in young 
adults with recurrent stroke. It also has impact on emotional, social and 
physical condition of the individual causing increasing burden in family 
and also on country income. 
ETIOLOGY: 
 Atherosclerotic – thrombotic and cerebral embolic stroke are the 
predominant cause of AIS. 
Atherosclerosis: It mainly involves large vessels like both intra-cranial and 
extra-cranial arteries and small vessels (lacunar arteries)(55). It mainly 
begins with damage to the endothelial lining of vessel wall. The damaged 
area attracts platelets, calcium, fatty substances, fibrin and cellular debri 
which accumulate to form an atherosclerotic plaque. These plaque 
eventually increase in size and block the blood flow through the vessel 
thereby decreasing the blood supply leading to hypoxia.  
These plaques become more vulnerable, when the lipid content increases in 
the plaque content within thin fibrous core.They become easily friable and get 
detached from the vessel form blood clots and flow easily in to the circulation 
and reach other areas and block the blood vessel(56). This denotes the second 
type of mechanism of stroke called cardio-embolic stroke. In both the 
mechanisms there will be vessel luminal stenosis as well as infiltration of 
vessel wall by inflammatory cells causing stiffness of vessel wall (57). 
Page | 24  
 
FIGURE 2: 
 
FIGURE 3: 
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Atheromatous plaques mostly form preferentially at branching points and 
curves of cerebral arteries. The most frequent sites involved are 
 Internal carotid artery at its origin from the common carotid artery 
 In the cervical part of vertebral arteries and at their junction to form 
basilar arteries 
 In the stem or at the main bifurcation of middle cerebral arteries 
 In the proximal posterior cerebral arteries as they wind around the 
midbrain 
 In the proximal anterior cerebral arteries as they pass anteriorly and 
curve around corpus callosum. 
The first three sites in the above mentioned are more frequent involved 
compared to cerebellar and ophthalmic arteries which are very less 
frequently involved. 
 Large artery disease : 
Carotid and vertebral dissections - Defined as tear in intimal layer of 
vessel leading to blood flow in between the layers of vessel wall. The 
stasis of blood in between the vessel layers leads to formation of clot 
which can thromboembolise leading to stroke(58). It plays a role in 
causing  stroke in young though it becomes a rare cause in older age group 
of stroke. Most commonly caused by trauma to blood vessel. It also causes 
haemorrhagic stroke in young adults. Spontaneous dissection is also seen 
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in few individuals. The predisposition for stroke increases if it is 
associated with connective tissue disorders. 
 Lacunar infarct (Small artery disease) : Systemic hypertension and 
Migraine effect the small microvasculature causing lacunar infarcts in the 
individuals. 
 Cardioembolism: It is the most common cause of arterial ischemic stroke 
(AIS) of all ages. It occurs very rapidly within seconds. The most common 
cause is atherosclerosis in older age group. It accounts of about one fifth 
of ischemic strokes(59). Whereas, this occurring in younger age group 
requires careful consideration as etiology varies comparatively. Most of 
the cases the emboli arises from a thrombus within heart. The arterial 
ischemic stroke caused by embolism from the heart can only be diagnosed, 
if at all there is an identifiable cardioembolic source which is the case in 
about 30% of ischemic stroke, by using transoesophageal 
echocardiography. It can provide the anatomic location of patients 
regarding the source of emboli. 
 Cardiac diseases – may be classified as congenital and acquired. 
o Congenital heart disease is a one of major risk factor for cardio-
embolic stroke especially in the perioperative period or following 
catheterization or extracorporeal membrane oxygenation (ECMO).  
o Rheumatic heart disease (RHD) – it plays a significant role in causing 
stroke in young adults in developing countries. About 3-8% strokes are 
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attributed by RHD. It also plays a role in recurrent stroke. It remains as 
an occult cause where early identification and preventive measures 
must be taken to reduce the incidence and recurrence(60). 
o Acquired conditions – this involves the most common cause of stroke. 
These commonly include Dilated cardiomyopathy (DCM), acute 
myocardial infarction (AMI), infective endocarditis (IE), Atrial 
Fibrillation (AF) and prosthetic valve placement. Coronary artery 
disease (CAD) share similar risk factors as that of stroke. left 
ventricular hypertrophy (LVH) and left atrial enlargement (LAE) 
further increases the relative risk of development of stroke(61). 
 Elevated Homocysteine levels : Inborn errors of metabolism 
characterized by defect in methionine metabolism due to deficiency of 
enzyme cystathione b-synthase(CBS). Common pattern of inheritance 
is autosomal recessive. Deficiency of vitamin B12 and serum folate 
levels is another factor having contributory role. These enzyme and 
vitamin deficiencies causes increased accumulation of homocysteine 
levels in plasma and urine. This elevated homocysteine levels causes 
endothelial dysfunction affecting both small and large vessels causing  
thromboembolic events(62). It is mainly diagnosed by measuring the 
levels of homocysteine in urine and plasma. Most of them respond to 
vitamin supplements. 
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 Fibromuscular dysplasia – This condition mainly affects the medium sized 
vasculature mostly in young women of childbearing age group. It causes 
medial fibrosis of vessel wall with an unknown mechanism, 
predominantly involving the carotid vasculature(63). Stroke may be of 
thromboembolic or vascular stenosis may be the underlying cause. On 
angiography, this shows a typical beading pattern of involved vessel. 
 Radiotherapy – Radiation received for head and neck malignancies are 
more prone to develop delayed onset of arterial ischemia stroke(64). 
Relative risk is doubled with radiotherapy. 
 Haematological disorders : 
o Thrombophilia: It is mainly defined as a group of condition related to 
impairment of haemostatic mechanism which manifest as increased 
tendency to form thrombus. They may be classified as inheritable or 
acquired conditions. Deficiency in natural coagulants like protein C, 
protein S and antithrombin III deficiency, polymorphisms in activated 
protein C and disturbance of clotting mechanisms by mutation in 
prothrombin gene 20210G/A are classified under the inheritable causes. 
Among the inherited conditions, Factor V leiden and prothrombin 20210 
mutation are most commonly associated with arterial ischemia 
stroke(AIS)(65).Among acquired conditions, Anti-phospholipid antibody 
syndrome (APLA) is most commonly associated with AIS. Acquired 
conditions are relatively at higher risk of causing stroke than inherited 
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conditions. People should undergo this workup with a background of prior 
episode suggestive of thromboembolic event or having a positive family 
history or recurrent pregnancy loss or no other identifiable risk 
factors(66). Screening among siblings and family members should be done 
for future prognostication.  
o Myeloproliferative syndromes – They mainly include polycthemiavera 
(PV), myelofibrosis and essential thrombocythemia (ET). They are 
described to have high prothrombotic states which mainly occurs due to 
inflammatory insult to the vessel wall by host immune response towards 
malignant cells. About 60-70% constitute the arterial thrombosis. The risk 
of thrombosis even further increases because of the use of myelo-
suppressive drugs(67). If associated with underlying valvular heart 
disease, there is a high risk of cardio-embolic stroke. ET affects 
microvasculature more. 
o Sickle cell anaemia – Stroke in this condition is most fatal complication 
with unknown pathogenesis. Considered mechanism in the etiology of 
stroke in this diseased condition is that, the deformed sickle cells cause 
vaso-occlussion of vessels leading to stroke. Another mechanism is by 
hemolysis within the vasculature altering the endothelial structure of 
vessel wall(68). This condition mainly affects the large arteries. 
o Vasculitides : Defined as occurrence of inflammation and formation of 
necrosis of vessel wall. It is classified as primary or secondary in nature. 
Page | 30  
 
Among the primary conditions Takayasu’s arteritis, Polyarteritisnodosa 
(PAN), Wegener’s granulomatosis (WG), Behcet’s are more common 
conditions associated with stroke in young individuals. Another rare 
feature called primary angitis of central nervous system (CNS) which is a 
multifocal disorder considered as one of the etiology of stroke in 
young(69). In these conditions, there is inflammation of blood vessel wall 
which increases the thrombogenecity and alter the vessel tone 
predisposing to stroke. Secondary causes like infections, collagen vascular 
diseases predispose to stroke which were excluded in this study(70). 
o Genetics: It may be single gene disorder or polygenic disorder or 
metabolic in nature.(TABLE 4) 
TYPES: 
 
GENE 
MUTATION 
VESSEL AFFECTED 
CADASIL Notch 3 receptor Small vessel disease 
CARASIL Notch 3 receptor Small vessel disease 
Fabry disease (X‐linked 
recessive) 
α‐galactosidase A Large and small vessel 
disease 
MELAS (maternal) Transfer RNA Complex 
Marfan syndrome (autosomal 
dominant) 
Fibrillin 1 Cardioembolism and 
arterial dissection 
Ehlers–Danlos syndrome 
(autosomal dominant) – type IV 
Collagen type III  
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o CADASIL (cerebral autosomal dominant arteriopathy with subcortical 
infarcts and leukoencephalopathy )- mutation causes progressive 
degeneration of smooth muscle cells in vessel wall causing stroke in 
late childhood or early adulthood(71). High risk for recurrent stroke in 
young. It is identified by classical MRI changes which shows bilateral 
temporal pole hyperintensity – punctate and nodular lesions. 
o CARASIL(cerebral autosomal recessive arteriopathy with subcortical 
infarcts and leukoencephalopathy ) – autosomally recessively inherited 
CADASIL associated with acute features of lumbago, spondylosis 
deformans, diffuse baldness and progressive mental and motor 
deterioration. Most common age of onset is 25-30years of age 
(younger age comparatively to CADASIL). On imaging , it is typically 
identified as diffuse and homogenous lesions. 
o MELAs – mitochondrial myopathy, encephalopathy, lacto-acidosis and 
stroke. It is a multisystemicmaternally inherited disorder which are 
characterised by stroke like episodes(72). In this condition mostly 
posterior regions like temporo-parietal and occipital regions are 
involved. Due to mitochondrial dysfunction, nitric oxide metabolism is 
impaired and free radicals are released which cause impairment of 
auto-regulation. Cardiomyopathy due to mitochondrial disease may 
cause cardio-embolic stroke. They are transient in nature and reflected 
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in abnormalities on neuroimaging(73). Muscle biopsy helps in 
diagnosing, by identifying the abnormal proliferation of mitochondria. 
o Fabry’s disease – X-linked genetic disorder where there is 
accumulation of lysosomes in vascular endothelium leading to 
narrowing of the vessels and infarction in affected young adult 
males(74). It involves brain, kidney, heart and skin. About 25% of 
individuals with fabry’s disease develop stroke involving both carotid 
and vertebrobasilar regions(75). Alpha galactosidase replacement 
decreased the incidence of cerebrovascular incidents. 
o Heritable disorders of connective tissue – This mainly involves the 
mutation in collagen and elastin which mainly constitute the main 
content of the vessel wall. Of the disorders affecting collagen fibres, 
Ehlers Danlos syndromes (EDS), osteogenenis imperfect (OI), 
autosomal dominant polycystic kidney disease (ADPKD) and collagen 
type IV related small vessel disease are most commonly associated 
with stroke(76). These are associated with formation of aneurysms in 
the vessel wall and are complicated with carotid and vertebral artery 
dissections. Among those affecting the elastin content of vessel wall, 
Marfan’s syndrome, LoeyzDietz syndrome (LDS type I and II) and 
pseudoxanthoma elasticum are commonly associated with occurrence 
of stroke in young. 
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o Amyloid angiopathy: It is associated with amyloid deposition in 
leptomeningeal walls and cerebral arteries and arterioles. Most 
commonly involves the occipital region and considered severe if it 
involves the same region. Mostly it causes haemorrhagic stroke. 
o Moyamoya disease : it is a genetic disorder with AD pattern of 
inheritance characterised by thickening of intimal carotid vessels. It 
has bimodal age pattern at age of 5 years and 30-50years of age(77). It 
mainly causes ischemic stroke in younger age group whereas 
associated with haemorrhagic stroke in adults. 
 
PATHOPHYSIOLOGY OF STROKE (FIGURE 4):  
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ANATOMY AND CLINICAL MANIFESTATIONS  
o ANATOMY OF CEREBRAL CIRCULATION: 
Brain is the highest perfused organ in the body. It receives about 20% of 
total circulation and also have maximum consumption of oxygen in the 
blood. It is mainly supplied by two pairs of large arteries – internal carotid 
arteries and vertebral arteries(78). 
Internal carotid artery supply about 3/5
th
 of cerebrum.The two vertebral 
arteries join together to form basilar artery which supplies cerebellum and 
brain stem. These two arterial circulation join together with the help of 
communicating branches to form circle of willis (COW)(79)(55). 
(FIGURE 5) 
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FIGURE 5: 
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o The internal carotid group produce three main vessel branches which 
include –   
1. Ophthalmic artery – supplies the meninges, contents of orbit. 
2. Anterior cerebral artery (ACA) – these are pair of arteries supplying 
the medial portions of frontal lobes along with prefrontal and 
supplementary motor cortex and superior medial parietal lobes. They 
are further subclassified into 5 smaller branches called callosal arteries 
as they also supply the carpus callosum. Due to collateral supply by 
anterior communicating artery, stroke due to ACA is very rare. 
o Clinical relevance –  
• Occlusion of ACA may cause following symptoms: 
• Contralateral lower limb upper motor neuron type (UMN) of 
weakness 
• Contralateral sensory loss in lower limb 
• Due to frontal lobe involvement – Behavioural abnormalities, 
cortical release reflexes – grasp reflex, sucking reflex, 
gegenhalten phenomenon. 
• Transcortical aphasia. 
3. Middle cerebral artery (MCA) – It also a paired artery which supplies 
anterior temporal and insular cortices. They are connected to ACA 
with the help of anterior communicating branches and connected with 
PCA with the help of posterior communicating branches. They are 
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further divided into 4 parts or segments in their course of supply. They 
supply the bulk of lateral surface of the hemispheres along with speech 
areas (Broca’s and Wernicke’s areas) 
o Clinical relevance –  
• Contralateral upper and lower limb UMN type of paralysis 
• Contralateral sensory loss over face and arm 
• If lenticulostriate branches of MCA are involved –  
 If involvement of dominant hemisphere  aphasia 
 Involvement of non-dominant hemisphere  
contralateral neglect syndrome  
4. Posterior cerebral artery (PCA) – it is one of the paired arteries which 
supply the posterior part of the brain which includes occipital lobe. It is 
divided into 2 branches – cortical and ganglionic vessels. 
o Clinical relevance –  
• Contralateral loss of pain and temperature 
• Contralateral homonymous hemianopia with macular sparing 
• Alexia and agraphia 
• Weber’s syndrome – third cranial nerve palsy with contralateral 
hemiplegia 
• Horner’s syndrome 
 
 
Page | 38  
 
FIGURE 6: 
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MANAGEMENT: 
NON INVASIVE METHODS: 
Patients with AIS, diagnosing stroke at early hand plays a key role in many 
ways: 
 To study the anatomical vasculature supplying the brain and also to 
determine the possible mechanism associated with occurrence of AIS. 
 To know the possible etiological association causing stroke in young 
adults. 
 In assessment of the clinical outcome and prognostication of the condition.  
 It helps for further management – mainly in the ED, where it plays a 
crucial role for diagnosis of AIS in order to decide about further 
management. 
Therefore, a standard approach for diagnosis and treatment for stroke in 
young adults must be established in a primary health care centres and standard 
educational institutions for management of stroke in emergency. 
 
DIAGNOSIS: Detailed clinical history from the patient or reliable attenders 
and rapid clinical examination plays a diligent role in diagnosis of AIS in ED. 
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FIGURE 7:
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It also helps in assessing the arterial territory involved and area of brain 
affected by examining clinically. 
 
Stroke scoring systems : Rapid assessment with the help scoring systems is 
needed in the patients with suspicion of stroke. several scoring scales are 
mainly used to assess the baseline characteristics for treatment outcome (80). 
In this study, clinical assessment by NIHSS scoring scale is used in the ED 
(used in this study) to know the severity of stroke at onset in young adults and 
used for prognosis and assess clinical outcome among them. These scales 
mainly help in improving accuracy of diagnosis of AIS and also help in 
determining the appropriate treatment and calculated outcome. No single 
scale will be able to assess all the effects of stroke that means not all 
parameters of stroke can be assessed completely by these scales. Several 
scoring scales are being designed and standardized, used varying on 
institutional presentation.  
Early imaging of brain either CT or MRI with or without angiography has to 
be done in the ED presented with suspicion of stroke. By doing this, 
haemorrhagic stroke is ruled out where the line of management differs from 
that of AIS. 
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Routine baseline investigations to be done are (TABLE 5): 
Complete haemogram  
Blood sugars Hypo or hyper glycemia 
Urine routine Diabetes , infection 
Serum electrolytes Hyponatremia or hypokalaemia or hyperkalaemia 
Renal function tests Renal failure 
Fasting lipids Dyslipidemia 
Homocysteine levels Homocystinemia 
Serology  Vasculitis , Infections, HIV, VDRL 
ECG Left ventricular hypertrophy (LVH), Atrial 
fibrillation, arrhythmias, AMI 
Echocardiography Infective endocarditis, atrial myxoma 
ESR, CRP Autoimmune causes-vasculitis, SLE 
To do :  
ANA profile, APLA APLA syndrome, SLE, vasculitis 
Coagulation profile Protein C and S deficiency, anti thrombin III 
deficiency, hyperfibrinogenemia. 
Genetic studies (optional)  CADASIL, MELAS, CARASIL.,etc 
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TREATMENT: 
Treatment is mainly aimed to reverse the hypoxic brain injury or lessen 
further damage of brain from hypoxia caused by decreased blood supply due 
to occlusion of the blood vessels supplying the brain. 
At the presentation to ED with acute stroke, the primary management is to 
assess the airway, breathing and circulation initially(81). Then treat the 
hypoglycaemia(<60mg/dl) on presentation identified as it may act as one of 
the stroke mimic.Hyperglycemia has poor outcomes of stroke. Hence, early 
treatment is needed. 
Blood pressure : Our goal is to reduce the blood pressure by 15% of initial 
presentation within 24hrs of onset provided if SBP > 220 mm Hg and DBP 
>120 mm Hg for AIS. 
 
 Early fibrinolysis : 
According to AHA/ASA guidelines for the management of AIS, it is indicated 
to thrombolyse patient with fibrinolytics in order to restore the blood flow to 
the brain and early resolution or neurological deficits. For this purpose, most 
commonly used fibrinolytic drug is r-tPA (recombinant tissue plasminogen 
activator). Streptokinase which has a major role in AMI, has high incidence of 
complications in acute AIS. Hence this drug is of not on regular use for AIS. 
Individual presented to ED must be identified by inclusion and exclusion 
criteria where patient is a feasible candidate for fibrinolysis(82). They must be 
Page | 44  
 
thrombolysed within a window period of maximum of 4.5hrs from the onset 
of symptoms.  
According to National institute of Neurological Disorders and Stroke 
(NINDS) and several other trials(83), the benefit of receiving t-PA is, no 
increased mortality and excellent recovery , outcomes the incidence of 
occurrence of intracerebral haemorrhage among receiving with t-PA. 
 
FIGURE 8: 
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CRITERIA FOR THROMBOLYSIS IN AIS:  
INCLUSION CRITERIA: 
 
 Onset of symptoms <3 hours before beginning treatment (Onset time is 
defined as either the witnessed onset of symptoms or the time last known 
normal) 
 Age ≥18 years  
 Informed consent - Potential risks and benefits of IV t-PA treatment 
discussed with patient and/or family members and they have verbalized 
understanding (to be documented in patient’s record). If patient unable to 
give verbal consent and no family available, IV t-PA can be given under 
Emergency Doctrine. Written informed consent not required for IV tPA 
when given within 3 hours of symptom onset.  
ABSOLUTE EXCLUSION CRITERIA  
 Significant head trauma or prior stroke in previous 3 months  
 Symptoms suggestive of any history of haemorrhage stroke 
 Intracranial neoplasm, arteriovenous malformation, or aneurysm  
 Recent intracranial or intra-spinal surgery  
 Elevated blood pressure (systolic >185 mm Hg or diastolic >110 mm Hg)  
 Active internal bleeding  
 Blood glucose concentration <50mg/dl (2.7mmol/L)  
 Acute bleeding diathesis, including but not limited to: Platelet count 
<1,00,000/mm³ (In patients without history of thrombocytopenia, 
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treatment with IV rtPA can be initiated before availability of platelet count 
but should be discontinued if platelet count is <100 000/mm³.)  
 Heparin received within 48 hours, resulting in abnormally elevated aPTT 
greater than the upper limit of normal  
 Current use of anticoagulant with INR >1.7 or PT >15 seconds and current 
use of direct thrombin inhibitors or direct factor Xa inhibitors with 
elevated sensitive laboratory tests (such as aPTT, INR, platelet count, and 
ECT; TT; or appropriate factor Xa activity assays)  
 CT demonstrates multilobar infarction (hypodensity>1/3 cerebral 
hemisphere)  
 
RELATIVE EXCLUSION CRITERIA : 
 Only minor or rapidly improving stroke symptoms (clearing 
spontaneously)  
 Seizure at onset with postictal residual neurological impairments  
 Major surgery or serious trauma within previous 14 days  
 Recent gastrointestinal or urinary tract haemorrhage (within previous 21 
days)  
 Pregnancy  
 
To extend IV tPA to 4.5 hours from symptom onset/last known normal, the 
following additional criteria MUST be met:  
 Patient is < 80 years of age  
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 Patient does not have a history of both diabetes AND stroke  
 Patient is not taking Warfarin (Coumadin) or any other anticoagulant 
regardless of INR/coagulation results  
 NIHSS is < 25  
 Written informed consent obtained from patient and/or family – required 
when IV tPA given within the 3-4.5 hour window.  
 
 Anti coagulants:  
Anticoagulation is not recommended in all the patients with AIS in 
emergency condition. Drugs most commonly use are low molecular weight 
heparin (LMWH) or unfractionated heparin (UFH)(84). They are generally 
used to prevent venous thromboembolism. But later recommendations suggest 
as of only with following specified clinical situations, anticoagulation therapy 
is indicated : 
 Conditions with potential high risk ofearly cardiogenic reembolization 
 Symptomatic dissection of arteries supplying the brain 
 Symptomatic extra-cranial or intra-cranial atheroscleroticstenosis  
 Basilar artery occlusion before or after intra-arterial pharmacological 
or mechanical thrombolysis 
 Known hypercoagulable states 
 Cerebral venous sinus thrombosis  
 
 Anti-thrombotic agents :  
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They are mainly used for secondary prevention of stroke. Drugs most 
commonly used are aspirin. Clopidogrel and extender release dipyridamole. 
Newer antiplatelets dabigatran, apixaban and rivaroxabanrae being studied for 
anticoagulation comparing with warfarin for primary end point (84). 
According to guidelines, aspirin should be given within 24 to 48hrs of onset 
of stroke to prevent mortality and primary end point.  
Endovascular techniques – intra-arterial fibrinolysis, thrombo-embolectomy, 
suction thrombectomy, angioplasty and revascularisation are few among 
known endovascular procedures. The main aim of these is to recanalise the 
thrombosed vessel to improve the blood flow. For this a team of skilled 
neurologists, interventional radiologists, anaesthesiology, nursing and 
technical support for optimal success.  
 
 Neuro protection:  
Several novel neuro-protective agents like citicholine, traxoprodil, ONO-
2506, magnesium, DP-b99 and NXY-059 have been identified. They limit the 
infarct size and improve functional outcome (primary end point)(85). They 
act as free radicals scavengers and inhibit further occurrence of neuronal cell 
death.  
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 Rehabilitation centres :  
The main aim of these centres is to improve the quality of life of stroke 
survivor by improving the skills to do the daily day to day activities. A team 
of neurologist, psychiatrist, occupational therapist, speech language 
therapists, dietician and social workers play an important role in achieving the 
desired result(86). 
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RESULTS  
In this study, about 50 consecutive cases admitted with AIS, which met 
inclusion and exclusion criteria are taken into the study. At presentation, 
along with complete history taking, relevant clinical examination, scoring was 
done, based on NIHSS and mRS scale in ED. The risk factors, etiology and 
clinical outcome were analysed in this study. 
GENDER: 
Among the study population of 50 patients, 36 (72 %) were males and 14 (28 
%) were females suffered with AIS.  
FIGURE 9: 
 
 
  
Male [n=36]
72%
Female[n=14]
28%
Sex Distribution [n=50]
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TABLE 6: 
Gender with Final 
mRS score             
  FINAL mRS SCORE 
Total Gender 
No 
Symptoms 
No 
significant 
disability 
Slight 
Disability 
Moderate 
Disability 
Severe 
Disability Dead 
Male 2 12 6 6 10 0 36 
Female 3 1 2 4 3 1 14 
Total 5 13 8 10 13 1 50 
 
Out of 36 males in the study, 10 had persistent severe disability and with 6 
each having mild to moderate disability and 2 have recovered completely 
from disability and symptoms. Among them, 2 had been death as final 
consequence.  
Among 14 females in the study, 3 had severe disability and 3 had recovered 
completely from the symptoms. Rest all were between of having mild to 
moderate disability. Only one among the female population had death as final 
consequence in the study. 
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FIGURE 10: 
 
 
Out of 50 patients, death occurred in about 3 patients. Among the females, 
death occurred among 1 patient accounting to mortality of 2%, whereas 
among males, 2 deaths out of 36 patients accounting to 2% of mortality. 
 
 
  
No 
Symptoms
No 
significant 
disability
Slight 
Disability
Moderate 
Disability
Severe 
Disability
Dead
Male 4% 24% 12% 12% 20% 0%
Female 6% 2% 4% 8% 6% 2%
0%
5%
10%
15%
20%
25%
30%
Gender with Final mRS [N=50]
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AGE: 
Among the age groups involved, most commonly patients were between 41-
45 years of age group constituting of 50% of total patients constituting if 
about 25 patients. Out of which 19 were males and 6 females. 
(TABLE 7)  
Age Distribution         
  SEX     
Age Male Female Total (%) 
< 30 2 1 3 6% 
31 - 35 1 5 6 12% 
36 - 40 14 2 16 32% 
41 - 45 19 6 25 50% 
Total 36 14 50 100% 
 
Between 36-40 years age group, constituted of about 32%(16 patients) of total 
study population. Out of which, 14(28%) were males and 2(4 %) were 
females. 6 patients with AIS (about 12%) were categorised under age group 
of 31-35years, out of which 1(2%) was male and 5(10%) were females. And 
about 3 patients, which is of about 6% of total study population fall under 
30years of age group, among which 2(4%) were males and 1 (2 %) was 
female. 
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(FIGURE 11): 
 
 
  
< 30 31 - 35 36 - 40 41 - 45
Male 4% 2% 28% 38%
Female 2% 10% 4% 12%
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TABLE 8: 
Age with Final mRS score 
  FINAL mRS SCORE 
Total Age  
No 
Symptoms 
No 
significant 
disability 
Slight 
Disability 
Moderate 
Disability 
Severe 
Disability Dead 
< 30 1 1 0 1 0 0 3 
31 - 35 1 0 1 2 1 1 6 
36 - 40 1 3 4 3 5 0 16 
41 - 45 2 9 3 4 7 0 25 
Total 5 13 8 10 13 1 50 
 
When correlating with final outcome with respect to age group of study 
population, 13 patients had persisting severe disability, out of which 7 were 
among the age group 41-45years, 5 were in between 36-40years and 1 was 
between 31-35years. 10 patients had moderate disability depending the 
ranking scale, 4 were under 41-45years, 3 were in between 36-40, 2 were 
among 31-35 years of age group and 1 was less than 30years of age. 
Among them, about 13 patients had complete recovery from clinical signs left 
with no disability and were able to carry out their regular activities with ease. 
Among them, 9 were under 41-45years of age group. About 5 patients had 
complete recovery of both signs and symptoms, among which 2 are under 41-
45 years of age group and rest of them 1 each among each category of age 
respectively. 
Death occurred among three patients in total study, 1 each which fall under 
the age groups of 41-45 years , 36-40years and 31-35 years category.   
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FIGURE 12: 
 
 
Risk factors: 
Among 50 patients observed, 29 were smokers, 3 chewed tobacco, 26 consumed 
alcohol. Among them, 24 patients had dyslipidemia, 13 had hyperrtension, 13 diabetes 
and only 7had heart disease. Out of 50, 5 had recurrent episode of stroke and about 3 
patients have been observed to have no associated risk factors. Other associated risk 
factorswhich constitute trauma, thyroid disorder, renal failure and bleeding disorders 
were observed in the study population.  
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Dead
< 30 2% 2% 0% 2% 0% 0%
31 - 35 2% 0% 2% 4% 2% 2%
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0%
2%
4%
6%
8%
10%
12%
14%
16%
18%
20%
Age with Final mRS [N=50]
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DYSLIPIDEMIA: 
TABLE 9: 
DYSLIPIDEMIA with Final 
mRS score           
  FINAL mRS SCORE 
Total DLP 
No 
Symptoms 
No 
significant 
disability 
Slight 
Disability 
Moderate 
Disability 
Severe 
Disability Dead 
YES 2 6 5 5 5 1 24 
NO 3 7 3 5 8 0 26 
Total 5 13 8 10 13 1 50 
 
Out of 50 patients, 24 patients had history of dyslipidemia. Among them with 
dyslipidemia, 1 patient got expired, 5 patients were left with persistent severe 
disability, 5 were with moderate and slight disability respectively. 8 were left with no 
disability and completely recovered from AIS. Patients who had no history of 
dyslipidemia, constituted about 26 patients of total population. Among them, 8 
patients were left with severe disability, 5 patients had moderate disability, 3 patients 
had mild disability. 10 patients had recovery with no disability. 
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FIGURE 13: 
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SMOKING: 
TABLE 10: 
Smoking with 
Final mRS score            
  FINAL mRS SCORE 
Total Smoker 
No 
Symptoms 
No 
significant 
disability 
Slight 
Disability 
Moderate 
Disability 
Severe 
Disability Dead 
YES 2 10 6 5 6 0 29 
NO 3 3 2 5 7 1 21 
Total 5 13 8 10 13 1 50 
 
Among 50 patients of study population, 29 patients were smokers ad 21 patients were 
non smokers. Among the smokers, 6patients had severe disability. 5 patients and 6 
patients had moderate to slight disability respectively. Total of 12 patients had no 
disability, out of which 2 patients recovered completely without signs and symptoms. 
Among the non-smokers, 1 patient had death and 7 patients had severe disability.5 
patients and 2 patients had moderate and slight disability respectively. 6 patients total 
have recovered clinically, out of which 3 had complete recovery from both signs and 
symptoms.  
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FIGURE 14:
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ALCOHOL: 
TABLE 11: 
Alcohol with Final mRS score 
  FINAL mRS SCORE 
Total Alcohol 
No 
Symptoms 
No 
significant 
disability 
Slight 
Disability 
Moderate 
Disability 
Severe 
Disability Dead 
YES 1 8 5 5 7 0 26 
NO 4 5 3 5 6 1 24 
Total 5 13 8 10 13 1 50 
 
Among the 50 patients, 26 patients were alcoholic and 24 patients were non-alcoholic. 
Out of 26 patients of alcoholics, 7 patients had severe disability. 5 patients each had 
moderate and slight disability respectively. 9 patients in total had complete recovery 
clinically, among which only had complete recovery from both signs and symptoms of 
stroke. Among the non-alcoholics, 1 had experienced death as final outcome. 6 
patients had severe disability. 5 patients and 3 patients had moderate and slight 
disability respectively. 9 patients had complete recovery clinically, among which 4 
had recovery completely from both signs and symptoms of stroke. 
FIGURE 15: 
 
No Symptoms
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Disability
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Disability
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Disability
Dead
YES 2% 16% 10% 10% 14% 0%
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Alcohol with Final mRS [N=50]
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DIABETES: 
TABLE 12: 
Diabetes with Final mRS score 
  FINAL mRS SCORE 
Total Diabetic 
No 
Symptoms 
No significant 
disability 
Slight 
Disability 
Moderate 
Disability 
Severe 
Disability Dead 
YES 1 2 3 2 5 0 13 
NO 4 11 5 8 8 1 37 
Total 5 13 8 10 13 1 50 
 
Among the study population, 13 patients had a history of diabetes mellitus and 37 
patients had no diabetes. Among the diabetics population, 5 patients had severe 
disability. 2 patients and 3 patients had moderate and slight disability respectively. 3 
patients had complete recovery clinically. Out of which 4 had complete recovery from 
both signs and symptoms. Among the non-diabetic population, 1 patient had death has 
final outcome. 8 patients had severe disability. 8patients and 5 patients had moderate 
and slight disability respectively. 15 patients were observed o have complete recovery 
clinically, among which 4 patients were completely free of even symptoms.  
FIGURE 16: 
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SYSTEMIC HYPERTENSION: 
TABLE 13: 
HYPERTENSION with Final mRS score 
  FINAL mRS SCORE 
Total SHT 
No 
Symptoms 
No significant 
disability 
Slight 
Disability 
Moderate 
Disability 
Severe 
Disability Dead 
YES 1 2 3 2 5 0 13 
NO 4 11 5 8 8 1 37 
Total 5 13 8 10 13 1 50 
 
Among the 50 patients, 13 patients were found to have hypertension and 37 patients 
were non hypertensive. Among the hypertensive group, 5 patients had severe 
disability. 2 patients and 3 patients had moderate and slight disability. 3 patients had 
complete recovery clinically and among them, 1 patient was completely 
symptomatically free. Among the non hypertensive patients, 1 patient has death as 
final consequence.8 patients had severe disability. 8 patients and 5 patients had 
moderate and slight disability. 15 patients had complete recovery clinically, among 
which 4 were completely symptomatically free. 
FIGURE 17: 
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ISCHEMIC HEART DISEASE(IHD): 
TABLE 14: 
IHD with Final mRS score 
  FINAL mRS SCORE 
Total IHD 
No 
Symptoms 
No significant 
disability 
Slight 
Disability 
Moderate 
Disability 
Severe 
Disability Dead 
YES 0 2 1 2 1 1 7 
NO 5 11 7 8 12 0 43 
Total 5 13 8 10 13 1 50 
 
Among the study populations, it has been observed that about patients had ischemic 
heart disease (IHD). 43 patients did not have any IHD. Among the HIS group of 
population, 1 patient had death. 1 patient had severe disability. 2 patients and 1 patient 
had moderate and slight disability respectively. 2 patients had complete recovery 
clinically. Among the non IHD group, 12 patients had severe disability. 8 patients and 
7 patients had moderate and slight disability respectively. 16 patients had complete 
recovery from stroke clinically , among which 5 patients were completely 
symptomatically free. 
FIGURE 18: 
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RECURRENT STROKE: 
Among the study population, 5 patients had history of stroke presented with recurrent 
stroke. Among the recurrent stroke population, None had death as final consequence. 
1(20%) patient had severe disability. 4 patients moderate and slight disability. 4(80%) 
patients had complete recovery from stroke clinically, among which 2(40%) patients 
were symptomatically free. 
 
NO RISK FACTORS: 
Among the study population, 3 patients had no risk factors or known comorbidities, 
presented with AIS. Among them, none had death as final consequence. 2 patients had 
severe disability. 1 patient had moderate disability. It has been observed that these 
patients had high NIHSS scores at presentation. They had persistent disability with no 
clinical improvement observed even after 3 months.  
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OTHERS: 
TABLE 15: 
Other Risk factors with Final mRS score 
  FINAL mRS SCORE 
Total 
Other Risk 
factors 
No 
Symptoms 
No 
significant 
disability 
Slight 
Disability 
Moderate 
Disability 
Severe 
Disability Dead 
YES 2 8 4 5 8 1 28 
NO 3 5 4 5 5 0 22 
Total 5 13 8 10 13 1 50 
 
Among the study population, 28 patients had association of other risk factors related 
to occurence with AIS. These risk factors included were seizure disorder, thyroid 
disorder, trauma, renal failure, history of cerebral venous thrombosis. Among these 
population, 1 had death as final consequence. 8 patients had severe disability. 5 
patients and 4 patients had moderate and slight disability. 10 patients had complete 
recovery from stroke clinically, among which 2 patients were symptomatically free. 
Among them with no other risk factors, 5 patients had severe disability. 5 patients and 
4 patients had moderate and slight disability. 8 patients had complete recovery from 
stroke clinically, among which 3 patients were symptomatically free. 
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FIGURE 19: 
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TABLE 16: 
CLINICAL VARIABLES WITH NIHSS SCORE 
      NIHSS 
Total 
CLINICAL 
VARIABLES 
  
Minor 
Stroke 
Moderate 
Stroke 
Moderate 
to Severe 
Stroke 
Severe 
stroke 
AGE 
< 30 Count 1 2 0 0 3 
% of Total 2.00% 4.00% 0.00% 0.00% 6.00% 
31 - 35 Count 1 2 2 1 6 
% of Total 2.00% 4.00% 4.00% 2.00% 12.00% 
36 - 40 Count 6 7 3 0 16 
% of Total 12.00% 14.00% 6.00% 0.00% 32.00% 
41 - 45 Count 9 10 5 1 25 
% of Total 18.00% 20.00% 10.00% 2.00% 50.00% 
SEX 
Male Count 12 19 4 1 36 
% of Total 24.00% 38.00% 8.00% 2.00% 72.00% 
Female Count 5 2 6 1 14 
% of Total 10.00% 4.00% 12.00% 2.00% 28.00% 
DLP 
Yes Count 8 11 3 2 24 
% of Total 16.00% 22.00% 6.00% 4.00% 48.00% 
No Count 9 10 7 0 26 
% of Total 18.00% 20.00% 14.00% 0.00% 52.00% 
SMOKER 
Yes Count 12 14 2 1 29 
% of Total 24.00% 28.00% 4.00% 2.00% 58.00% 
No Count 5 7 8 1 21 
% of Total 10.00% 14.00% 16.00% 2.00% 42.00% 
ALCOHOL 
Yes Count 9 14 2 1 26 
% of Total 18.00% 28.00% 4.00% 2.00% 52.00% 
No Count 8 7 8 1 24 
% of Total 16.00% 14.00% 16.00% 2.00% 48.00% 
DIABETIC 
Yes Count 5 4 4 0 13 
% of Total 10.00% 8.00% 8.00% 0.00% 26.00% 
No Count 12 17 6 2 37 
% of Total 24.00% 34.00% 12.00% 4.00% 74.00% 
SHT 
Yes Count 8 6 3 1 18 
% of Total 16.00% 12.00% 6.00% 2.00% 36.00% 
No Count 9 15 7 1 32 
% of Total 18.00% 30.00% 14.00% 2.00% 64.00% 
IHD 
Yes Count 3 2 1 1 7 
% of Total 6.00% 4.00% 2.00% 2.00% 14.00% 
No Count 14 19 9 1 43 
% of Total 28.00% 38.00% 18.00% 2.00% 86.00% 
OTHERS 
Yes Count 7 13 6 2 28 
% of Total 14.00% 26.00% 12.00% 4.00% 56.00% 
No Count 10 8 4 0 22 
% of Total 20.00% 16.00% 8.00% 0.00% 44.00% 
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CLINICAL PRESENTATION 
There were varied clinical presentations among the patients in this study. Out of 50 
patients, 34 of them presented with motor weakness of limbs over the involved side. 9 
of them presented with giddiness.3 patients had presented with blurring of vision. 
Whereas, about 4 patients had presented with both weakness and giddiness to the ED. 
One patient had presented with both weakness and blurring of vision.  
Among the study patients, clinically other associated symptoms were accompanied 
apart from these main presenting symptoms of limb weakness, giddiness and blurring 
of vision. These included drowsiness, vomiting, speech abnormalities, numbness, 
headache, ataxia, diplopia and loss of consciousness. Among the associated 
complaints, 26 patients had speech abnormalities. About 10 patients were found to be 
drowsy at initial presentation and 8 patients had ataxia at presentation to ED. 6 
patients of total had numbness, 3 patients with complaint of headache and2had 
complaint of vomiting during presentation to ED. Out of total study population, only 
one had history of loss of consciousness. 
Among the study population, 34 patients presented with weakness of limbs. Out of 
them, 1 had death as final consequence. 11 patients had severe disability. 8 patients 
and 4 patients had moderate and slight disability. 10 patients had complete recovery 
from stroke clinically, among which 2 patients were symptomatically free. About 9 
patients presented with giddiness as main presenting symptom. Among them 2 
patients had severe disability. 
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TABLE 17: 
ASSOCIATED SYMPTOMS NUMBER (PERCENTAGE) 
Speech abnormalities 26 (52%) 
Drowsiness  10 (20%) 
Ataxia 8 (16%) 
Numbness 6 (12%) 
Headache 3 (6%) 
Vomiting  2 (4%) 
Diplopia 1 (2%) 
Loss of consciousness 1 (2%) 
 
1 patient and 3 patients had moderate and slight disability. 3 patients had complete 
recovery from stroke clinically, among which 2  patients were symptomatically free. 
In the study group, 2 patients presented with blurring of vision as main presenting 
symptom. Out of them 1 had slight disability and 1 had complete recovery clinically 
and symptomatically. 
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TABLE 18: 
Clinical Signs with Final mRS score  
  FINAL mRS SCORE 
Total Clinical Signs 
No 
Symptoms 
No 
significant 
disability 
Slight 
Disability 
Moderate 
Disability 
Severe 
Disability Dead 
Weakness(W) 2 8 4 8 11 1 34 
Giddiness(G) 1 2 3 1 2 0 9 
Blurring of 
vision(B) 0 1 1 0 0 0 2 
W,G 1 2 0 1 0 0 4 
W,B 1 0 0 0 0 0 1 
Total 5 13 8 10 13 1 50 
 
In the group, 4 patients had presented with both weakness of limbs and giddiness as 
initial manifestation. Among them, one had moderate disability.3 patients had 
complete recovery from stroke clinically, among which one patient was 
symptomatically free. And about one patient had presented with weakness and 
blurring of vision as initial manifestation. It was observed that this patient had 
complete recovery from stroke both symptomatically and clinically. 
FIGURE 20: 
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Speech: 
About 26 patients of total study population had been observed to have speech 
abnormalities. Among them, 1 had death as final consequence. 11 patients had severe 
disability. 6 patients and 3 patients had moderate and slight disability. 5 patients had 
complete recovery from stroke clinically, among which one patient was 
symptomatically free.  
TABLE 19: 
Speech with Final mRS score    
  FINAL mRS SCORE 
Total Speech 
No 
Symptoms 
No significant 
disability 
Slight 
Disability 
Moderate 
Disability 
Severe 
Disability Dead 
YES 1 4 3 6 11 1 26 
NO 4 9 5 4 2 0 24 
Total 5 13 8 10 13 1 50 
 
Among the population with no speech abnormalities, 2 patients had severe disability. 
4 patients and 5 patients had moderate and slight disability. 13 patients had complete 
recovery from stroke clinically, among which 4 patients were symptomatically free. 
FIGURE 21: 
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TABLE 20: 
CLINICAL VARIABLES WITH NIHSS SCORE   
      NIHSS 
Total 
Sig 
CLINICAL 
VARIABLES 
    
Minor 
Stroke 
Moderate 
Stroke 
Moderate 
to Severe 
Stroke 
Severe 
stroke 
CLINICAL SIGNS 
 
% of Total 12.00% 34.00% 18.00% 4.00% 68.00% 
G Count 5 3 1 0 9 
% of Total 10.00% 6.00% 2.00% 0.00% 18.00% 
B Count 2 0 0 0 2 
% of Total 4.00% 0.00% 0.00% 0.00% 4.00% 
WG Count 3 1 0 0 4 
% of Total 6.00% 2.00% 0.00% 0.00% 8.00% 
WB Count 1 0 0 0 1 
% of Total 2.00% 0.00% 0.00% 0.00% 2.00% 
LIMBS 
1 Count 5 1 1 0 7 
0.04 
% of Total 11.60% 2.30% 2.30% 0.00% 16.30% 
2 Count 5 19 9 2 35 
% of Total 11.60% 44.20% 20.90% 4.70% 81.40% 
4 Count 1 0 0 0 1 
% of Total 2.30% 0.00% 0.00% 0.00% 2.30% 
SPEECH 
Yes Count 3 12 9 2 26 
0.001 
% of Total 6.00% 24.00% 18.00% 4.00% 52.00% 
No Count 14 9 1 0 24 
% of Total 28.00% 18.00% 2.00% 0.00% 48.00% 
SENSORY 
Yes Count 0 2 4 0 6 
0.017 
% of Total 0.00% 4.00% 8.00% 0.00% 12.00% 
No Count 17 19 6 2 44 
% of Total 34.00% 38.00% 12.00% 4.00% 88.00% 
CEREBELLAR 
Yes Count 1 2 1 0 4 
0.941 
% of Total 2.00% 4.00% 2.00% 0.00% 8.00% 
No Count 16 19 9 2 46 
% of Total 32.00% 38.00% 18.00% 4.00% 92.00% 
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In this study, it has been observed that cranial nerve involvement was also most 
frequently involved among the patients with AIS. Out of 50 patients of study 
population, 25 patients were found to have involvement of cranial nerves. Out of 
which, 7
th
 cranial nerve was most commonly affected. 7
th
 cranial nerve involvement 
was seen in about 21 patients out of total 25 patients with cranial nerve involvement. 
Next frequently involved was seen were 3
rd
, 4
th
 and 6
th
 cranial nerves. It is observed in 
3 patients of total of 25 patients associated with cranial nerve involvement. Less 
commonly, in one patient each 8
th
 and 12
th
 cranial nerves were involved respectively. 
TABLE 21: 
CRANIAL NERVES with Final mRS 
score           
  FINAL mRS SCORE 
Total Cranial Nerves 
No 
Symptoms 
No 
significant 
disability 
Slight 
Disability 
Moderate 
Disability 
Severe 
Disability Dead 
2 0 1 0 0 0 0 1 
7 2 3 2 7 4 0 18 
7,8 0 1 0 0 0 0 1 
7,12 0 0 1 1 0 0 2 
3,4,6 0 0 1 0 0 0 1 
2,3,4,6 1 0 1 0 0 0 2 
NIL 2 8 3 2 9 1 25 
Total 5 13 8 10 13 1 50 
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FIGURE 22:
 
 
ETIOLOGY: 
Stroke was classified into subtypes, according to Trial of Org 10172 in Acute Stroke 
Treatment (TOAST) criteria in this study. According to this criteria, 20 patients of 
them have had atherosclerosis as main etiological association with occurrence of 
stroke.About 8 patients were sub grouped to have cardio-embolic stroke. Among the 
50 patients, 4 were grouped to have lacunar infarct and 9 patients were found to have 
stroke due to other etiology. Out of 50 patients, 9 patients were found to have stroke 
of undetermined etiology, where the cause of stroke in these individuals was not 
identified so far. 
 
No Symptoms
No significant 
disability
Slight 
Disability
Moderate 
Disability
Severe 
Disability
Dead
2 0% 2% 0% 0% 0% 0%
7 4% 6% 4% 14% 8% 0%
7,8 0% 2% 0% 0% 0% 0%
7,12 0% 0% 2% 2% 0% 0%
3,4,6 0% 0% 2% 0% 0% 0%
2,3,4,6 2% 0% 2% 0% 0% 0%
NIL 4% 16% 6% 4% 18% 2%
0%
2%
4%
6%
8%
10%
12%
14%
16%
18%
20%
Cranial nerves with Final mRS [N=50]
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TABLE 22: 
ETIOLOGY N 
ATHEROSCLEROSIS 20 
CARDIOEMBOLIC 8 
LACUNAR INFARCT 4 
OTHER ETIOLOGY 7 
UNKNOWN ETIOLOGY 11 
Total 50 
 
FIGURE 23: 
 
 
Among the other etiology, involved in this study are hyperhomocystinemia (2 out of 
8), antiphospholipid antibody syndrome(2 out of 8) and autoimmune causes (4 out of 
8). In total, about 13 patients had hyperhomocystinemia, of which 11 had significant 
association with atherosclerosis causing arterial ischemic stroke in the study 
population. 
 
 
 
ATHEOSCLEROSIS
40%
CARDIOEMBOLIC
16%
LACUNAR INFARCT
8%
OTHER ETIOLOGY
16%
UNDETERMINED
20%
Etiology [n=50]
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Area involved: 
TABLE 23: 
Areas of involvement N 
MCA 41 
PCA 4 
ACA 2 
MCA + PCA 3 
 
Among 50 patients in the study, 41 patients were found to have stroke involving MCA 
territory. 4 patients were found to have AIS involving the PCA territory. 2 patients 
found to have involvement of ACA territory. Out of all, 3 patients had involvement of 
both MCA and PCA territories 
FIGURE 24: 
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Side of involvement: 
TABLE 24: 
Sides of involvement n 
Right 19 
Left 30 
Bilateral 1 
 
Out of 50 patients with AIS, 30 patients were found to have involvement of left sided 
territories. Among  the 50, 19 patients found to have right sided involvement. Only 
one patient had involvement of both sides. Among them, apart from predominant 
involvement of left side, also more severity is also associated with left sided 
involvement at presentation based on NIHSS scoring scales at baseline. Nearly, 7 out 
of 30 (23%) were categorised into moderately severe to severe stroke at presentation. 
Right sided were categorised under minor - moderate stroke at initial presentation. 
 
FIGURE 25: 
 
Right
38%
Left
60%
Bilatera
2%
Side of involvement [n=50]
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INITIAL mRS WITH FINAL mRS: 
Among the study population, about 25 patients were classified to have severe 
disability at initial presentation in ED. Among them, one patient had death as final 
consequence. 13 patients persisted to have severe disability. 11 patients had moderate 
disability still dependent for daily regular activities. About 2 patients had recovery 
with having slight disability as final outcome after 3 months of assessment. 
In the study group, 10 patients had moderate disability at initial presentation to ED. 
Among this group of population, only one patient had persistent to have moderate 
disability. 3 patients had slight disability. About 6 patients of this group had total 
recovery clinically. 
TABLE 25: 
Initial MRS with Final MRS score  
  FINAL MRS SCORE 
Total MRS 
No 
Symptoms 
No 
significant 
disability 
Slight 
Disability 
Moderate 
Disability 
Severe 
Disability Dead 
No significant disability 4 4 0 0 0 0 8 
Slight disability 1 3 3 0 0 0 7 
Moderate disability 0 6 3 1 0 0 10 
Severe disability 0 0 2 9 13 1 25 
Total 4 13 8 10 13 1 50 
 
Among the study group, about 7 patients were classified to have slight disability at 
initial presentation in ED. Among them, 3 patients persisted to have slight disability 
showing no improvement. 4 patients had recovery complete recovery clinically, of 
which one patient showed complete symptomatic improvement. 
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In this study group, 8 patients had no significant disability at initial presentation to 
ED. Among these group of population, 4 patientspersisted to have symptomatic 
disability. 4 patients were completely relieved of symptoms and clinically showed no 
disability. 
 
FIGURE 26: 
 
 
  
No 
Symptoms
No 
significant 
disability
Slight 
Disability
Moderate 
Disability
Severe 
Disability
Dead
no significant disability 8% 8% 0% 0% 0% 0%
slight disability 2% 6% 6% 0% 0% 0%
moderate disability 0% 12% 6% 2% 0% 0%
severe disability 0% 0% 4% 18% 26% 2%
0%
5%
10%
15%
20%
25%
30%
Initial mRS with Final mRS [N=50][p<0.001]
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FINAL OUTCOME (FINAL mRS) (FIGURE 27): 
 
 
FINAL OUTCOME (FINAL mRS) WITH INITIAL NIHSSSCORING: 
About of total of 50 patients involved in the study, patients were given NIHSS scoring 
at initial presentation in ED. Outof 50 patients, 2 patients presented with severe stroke 
with NIHSS scoring between 21-42, of which one patient had death as final outcome 
and other patient had slight disability.About 10 patients were classified to have 
moderate to severe stroke with NIHSS scoring of 16-20. Among this group, 6 patients 
had severe disability. 3 patients had moderate disability and one patient had 
improvement with slight disability as final outcome.  
 
  
No Symptoms [n=5]
10%
No significant 
disability [n=13]
26%
Slight disability 
[n=8]
16%
Moderate 
disability[n=10]
20%
Severe 
disability[n=13]
26%
Dead[n=1]
2%
Final mRS 
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TABLE 26: 
NIHSS with Final mRS score      
  FINAL mRS SCORE 
Total NIHS 
No 
Symptoms 
No 
significant 
disability 
Slight 
Disability 
Moderate 
Disability 
Severe 
Disability Dead 
Minor Stroke 5 7 5 0 0 0 17 
Moderate Stroke 0 6 1 7 7 0 21 
Moderate to Severe 
Stroke 0 0 1 3 6 0 10 
Severe stroke 0 0 1 0 0 1 2 
Total 5 13 8 10 13 1 50 
 
About 21 patients were classified under moderate stroke with NIHSS scoring of 5-15. 
Among this study population, 7 patients had persistent severe disability. 7 patients had 
moderate disability and one patients had slight disability. 6 patients found to have 
complete recovery clinically. About 17 patients presented to ED initially were 
classified to have minor stroke according to NIHSS scoring of 0-4. Out of which, 5 
had slight disability as final outcome after 3 months. 12 patients had complete 
recovery clinically, of which 5 patients had completely symptomatic free. 
FIGURE 28: 
 
No Symptoms
No significant 
disability
Slight 
Disability
Moderate 
Disability
Severe 
Disability
Dead
YES 0% 4% 2% 0% 2% 0%
NO 10% 22% 14% 20% 24% 2%
0%
5%
10%
15%
20%
25%
30%
NIHSS with Final mRS [N=50][p<0.001]
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DISCUSSION 
Stroke among young adults has been increasing in incidence in the recent times. 
Identification of risk factors and etiology play a crucial role in reducing the morbidity 
and financial burden in the society.  
In this study, 50 consecutive cases of stroke among young individuals fulfilling 
inclusion and exclusion criteria were taken in the study. 
• In concordance with the other studies in India, predominance of stroke was 
seen among males in study population(36 out of 50).The mean age observed 
was 39 years, with highest incidence of stroke was seen in 4th decade 
accounting about 50% falling between the age group 40-45years. 
• Smoking, alcoholism and dyslipidemia have been found to be significantly 
associated with stroke. Whereas, other studies from India showed smoking, 
diabetes and hypertension to be prevalant risk factors. Diabetes and ischemic 
heart disease was found to have a very low association with the occurence of 
stroke among young individuals in the study. 
• Hyper-homocystinemia has significant association with the causation of stroke 
in the young individuals. Of which, 18.4% was observed with atherosclerosis 
contributing to the evidence of its pro-thrombotic role in occurrence of stroke 
in the young adults. 
• Recurrence of stroke though was seen in 10%, but no mortality and less 
morbidity has been observed among these patients. Patients with no known 
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associated risk factors were found to have initial severe presentation with 
persistent clinical morbidity. 
• Most common clinical finding was hemiplegia with seventh cranial nerve 
palsy. Majority have left sided involvement associated with significant speech 
abnormalities, observed in this study. They have significant association with 
prolonged morbidity compared to that among right sided involvement. 
• In concordance with other studies in India, Atherosclerosis remains the major 
etiological association of ischemic stroke in this study. Whereas, still in about 
20% of total population, etiology of arterial ischemic stroke was undetermined. 
• Vitamin D deficiency also has contributory role among the dividuals affected 
with stroke. With respect to a meta-analysis in August 2012, risk of stroke was 
observed with Vitamin D deficiency among the study population due to its 
effect on the vasculature. It also has long term effect on morbidity among 
stroke patients. 
• NIHSS scoring scale is one among the best scoring scales for predicting the 
outcome and prognosis of the young individuals presented with stroke. NIHSS 
scoring at initial presentation, most of them were graded to have moderate and 
minor stroke. Significant disability seen among the individuals with higher 
NIHSS scores at baseline there by increase in morbidity. 
• Initial mRS scoring also has significant impact on the final outcome among the 
study population. Initially with severe disability were found to have persistent 
disability even after three months thereby increasing the morbidity and 
affecting the financial and economic aspects of family. 
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CONCLUSION 
• Stroke among young individuals is a major health issue and remains a 
diagnostic challenge comparatively to that among elderly.(40) It is anticipated 
that increase in prevalence of stroke among young individuals by 2050. (34, 
35) 
• In this study , males have higher incidence of developing stroke compared to 
females (Male : Female = 2.6 : 1) 
• Most of the study population, are among age group between 41-45years. The 
least age observed to have developed stroke is 21 years. 
• It has been observed that smoking, alcohol,dyslipidemia are the modifiable risk 
factors in the decreasing order of frequency found to have significant 
association occurring in higher incidence among the study population 
• Whereas, incidence of heart diseases, diabetes and family history observed to 
be low in this study.With no underlying risk factors, there was found to have 
higher morbidity. 
• Clinically, weakness was the predominant symptom observed. Speech 
involvement has a higher incidence and also has significant impact on final 
outcome among the study population. Involvement of seventh cranial nerve is 
frequently observed among the study group. 
• Atherosclerosis was the main etiological association with young stroke in this 
study. 
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• Despite the lack of absolute accuracy of classification models, scoring systems 
that have good predictive accuracy can play an important role in assessing the 
severity and outcome of stroke. they also help in prognostication of patients 
with acute stroke. 
• Proper history taking plays a major role among the young population. 
Identification and modification of risk factors have a consequential effect on 
the individual and the society. 
• Vitamin D deficiency has both causative and long term effect among the stroke 
patients. More studies are needed for its in role in occurence of stroke and also 
its impact on the morbidity. 
• Extensive etiological evaluation for the stroke in young individuals is needed 
and managed accordingly which has a significant impact on the outcome of the 
individuals.  
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 PROFORMA 
 Name  
 Age 
 Sex 
 Address  
 Occupation  
 Chief  complaints 
 H/o  cocaine  abuse  or  any  other  substance  abuse  or  use  of  oral  
contraceptives 
 H/o  smoking,  alcohol,  diabetes,  hypertension,  seizure  disorder,  
bleeding  disorders,  migraine, thrombosis,  rheumatic  heart  disease,  
ischaemic  heart  disease,  severe  LV  dysfunction, arrhythmias (mainly  
atrial  fibrillation) 
 H/o  head  trauma  
 Family  history  of  thrombosis,  hyperlipidaemia,  hypertension, diabetes 
 
 
 
 
 
 
 
 
 CLINICAL EXAMINATION 
 General examination 
 CNS examination: 
o Speech – dysarthria or aphasia (motor / sensory/ global) 
o Cranial nerves 
o Weakness of limb – 1 UL or 1 UL and 1 LL or 4 limbs 
o Power – UL and LL 
o Sensory  
o Cerebellar  
o Carotid and subclavian bruits, murmurs 
o Peripheral pulses 
o NIHSS on admission 
o mRS on admission and after 3 months 
 Routine investigations: 
o Complete blood count, Diabetic profile 
o Serum electrolytes, urine routine and microscopy 
o ECG, ECHO, serum homocysteine levels 
o CT- brain plain, MRI brain with angiography 
 Other investigations: 
o ANA IF and Antiphospholipid antibodies  
 If needed:  
o Complete coagulation work up 
o Genetic testing 
 ABBREVIATIONS 
AIS  –  Arterial ischemic stroke 
WHO   - World  Health  Organization  
TOAST  -  Trial of Org 10172 in Acute Stroke Treatment (TOAST)  
criteria. 
ANA   –  Anti nuclear antibody profile 
APLA  –  Anti-phospholipid antibody 
CT   –  Computed tomography 
MRI   –  Magnetic resonance imaging  
NIHSS  -  National  Institute  of  Health  stroke  scale 
mRS   –  modified rankin scoring 
TIA   -  Transient ischemic attacks  
ICMR  - Indian Council Medical Research  
DALY -  disability life adjusted years  
LDL-C  -  low-density lipoprotein cholesterol  
TGL   -  Triglycerides  
HDL-C  - High-density lipoprotein cholesterol (HDL-C) 
BMI   –  Body mass index 
 SBP   –  Systolic blood pressure 
DBP   –  Diastolic blood pressure 
FBS   -  fasting blood glucose 
HbA1c  -  glycosylated haemoglobin  
DM   –  Diabetes mellitus 
MA   –  Migraine headache with aura  
ECMO –  Extracorporeal membrane oxygenation 
RHD   - Rheumatic heart disease 
DCM   -  Dilated cardiomyopathy  
AMI   –  Acute myocardial infarction 
IE   –  Infective endocarditis 
AF   –  Atrial Fibrillation  
CAD   –  Coronary artery disease  
LVH   –  Left ventricular hypertrophy 
LAE   –  Left atrial enlargement  
CBS   – Cystathione b-synthase 
PV   –  Polycthemiavera 
ET   -  Essential thrombocythemia 
 PAN   –  Polyarteritisnodosa 
WG    –  Wegener’s granulomatosis  
CNS   -  Central nervous system  
CADASIL  –  Cerebral autosomal dominant arteriopathy with  
subcortical infarcts and leukoencephalopathy 
CARASIL  –  Cerebral autosomal recessive arteriopathy with  
subcortical infarcts and leukoencephalopathy 
MELAs  –  Mitochondrial myopathy, encephalopathy, lacto-acidosis  
and stroke 
EDS   –  Ehlers Danlos syndromes  
OI   –  Osteogenenis imperfect  
ADPKD  -  Autosomal dominant polycystic kidney disease  
LDS   -  Loeyz Dietz syndrome  
AD   –  Autosomal dominant 
COW   –  Circle of willis 
ACA   –  Anterior cerebral artery 
MCA   –  Middle cerebral artery 
PCA   –  Posterior cerebral artery 
UMN   –  Upper motor neuron type  
 ED   –  emergency department 
HIV   –  human immunodeficiency virus 
ECG   –  Electrocardiogram 
ECHO  –  Echocardiography 
AHA/ASA  –  American heart association / American stroke  
association 
r-tPA   –  Recombinant tissue plasminogen activator 
NINDS  –  National institute of Neurological Disorders and Stroke 
aPTT   –  Activated partial thromboplastin time  
INR   –  International normalised ratio 
PT   –  Prothrombin time 
UFH   –  Unfractionated heparin 
LMWH  – Low molecular weight heparin 
 
 
 
 
 
 CONSENT FORM 
PSG Institute of Medical Science and Research, Coimbatore 
Institutional Human Ethics Committee 
INFORMED CONSENT FORMAT FOR RESEARCH PROJECTS 
 
(strike off items that are not applicable) 
 
 
I / We (write name of the investigator(s) here), Dr. KARRI MADHAVI,  am 
carrying out a study on the topic: ETIOLOGY AND CLINICAL OUTCOME 
OF STROKE IN YOUNG ADULTS(18-45years) ADMITTED IN A 
TERTIARY CARE HOSPITAL.  
 
as part of my / our research project being carried out under the aegis of the 
Department of: GENERAL MEDICINE  
 
(Applicable to students only): My / our research guide is: Dr. SUJITH 
KUMAR S M.D 
 
The justification for this study is:  
Considering the disease burden and the morbidity and mortality associated 
with specific etiology of stroke in young adults admitted which is essential to 
reduce the socioeconomic burden in the family, to treat and also for further 
prevention of recurrence. 
 
The objectives of this study are:  
 
Primary Objective: To study the etiology and clinical outcome in stroke of 
young adults  
 
Secondary Objective: To know the morbidity and mortality in the stroke of 
young adults 
 
Sample size: 50  
 
Study volunteers / participants are (specify population group & age group): 
Patients between 18-45years admitted with stroke  
 
Location: PSG Hospitals, Coimbatore.  
 
We request you to kindly cooperate with us in this study. We propose collect 
background information and other relevant details related to this study. We 
will be carrying out:  
 Initial interview (specify approximate duration):__________ minutes.  
 
Data collected will be stored for a period of __TWO__ years. We will / will 
not use the data as part of another study. 
 
Health education sessions: Number of sessions: _____________. 
Approximate duration of each session:  
 
______________ minutes.  
 
Clinical examination (Specify details and purpose): To assess the general 
condition and systemic examination 
 
Blood sample collection: Specify quantity of blood being drawn: __5__ml.  
 
No. of times it will be collected: ONCE  
 
Whether blood sample collection is part of routine procedure or for research 
(study) purpose:  RESEARCH 
 
1. Routine procedure 2. Research purpose  
 
Specify purpose, discomfort likely to be felt and side effects, if any: 
__NIL___ 
 
Whether blood sample collected will be stored after study period:  No, it will 
be destroyed 
 
Whether blood sample collected will be sold:  No  
 
Whether blood sample collected will be shared with persons from another 
institution:  No 
 
Medication given, if any, duration, side effects, purpose, benefits: NIL 
 
Benefits from this study:  TO ASSESS THE ETIOLOGY SO THAT IT CAN 
BE USED FOR PRIMARY AND SECONDARY PREVENTION OF 
STROKE IN YOUNG ADULTS (18-45 YEARS). 
 
Risks involved by participating in this study: NIL 
 
How the results will be used: Study will be submitted to Dr. MGR Medical 
University as thesis in post graduate course in general medicine.  
 
 If you are uncomfortable in answering any of our questions during the course 
of the interview / biological sample collection, you have the right to 
withdraw from the interview / study at anytime. You have the freedom to 
withdraw from the study at any point of time. Kindly be assured that your 
refusal to participate or withdrawal at any stage, if you so decide, will not 
result in any form of compromise or discrimination in the services offered nor 
would it attract any penalty. You will continue to have access to the regular 
services offered to a patient. You will NOT be paid any remuneration for the 
time you spend with us for this interview / study. The information provided 
by you will be kept in strict confidence. Under no circumstances shall we 
reveal the identity of the respondent or their families to anyone. The 
information that we collect shall be used for approved research purposes only. 
You will be informed about any significant new findings - including adverse 
events, if any, – whether directly related to you or to other participants of this 
study, developed during the course of this research which may relate to your 
willingness to continue participation. 
 
Consent: The above information regarding the study, has been read by me/ 
read to me, and has been explained to me by the investigator/s. Having 
understood the same, I hereby give my consent to them to interview me. I am 
affixing my signature / left thumb impression to indicate my consent and 
willingness to participate in this study (i.e., willingly abide by the project 
requirements).  
 
Signature / Left thumb impression of the Study Volunteer / Legal 
Representative:  
 
 
 
Signature of the Interviewer with date:     
 Witness: 
 
Contact number of PI: 08754189611 
 
Contact number of Ethics Committee Office:  0422 2570170 Extn.: 5818 
 
 
 
 
 
 ´ôÒ¾ø ÀÊÅõ 
§¾¾¢ :   
 
¸Ã¢ Á¡¾Å¢, ¬¸¢Â ¿¡ý, À¢. ±Š. ƒ¢. ÁÕòÐÅì ¸øæÃ¢Â¢ý, ¦À¡Ð ÁÕòÐÅ Ð¨ÈÂ¢ý 
¸£ú, “ãýÈ¡õ ¿¢¨Ä ÁÕòÐÅÁ¨ÉÂ¢ø «ÛÁ¾¢ì¸ôÀÎõ þÇõ ÅÂ¾¢ø (18-45 
ÅÂ¾¢üÌû) ²üÀÎõ Àì¸Å¡¾ò¾¢ü¸¡É ¸¡Ã½í¸Ùõ, Å¢¨Ç×¸Ùõ” ±ýÈ ¾¨ÄôÀ¢ý 
¸£ú ¬ö× §Áü¦¸¡ûÇ ¯û§Çý. 
±ý ¬ö× ÅÆ¢¸¡ðÊ:  ÁÕòÐÅ÷. Íƒ¢òÌÁ¡÷ 
¬ö× §Áü¦¸¡ûÅ¾ü¸¡É «ÊôÀ¨¼:  
§¿¡öì¸¡É ¸¡Ã½ò¨¾ «È¢Å¾ý ãÄõ ÁÚÀÊÔõ «ó§¿¡ö ÓüÚÅ¨¾ ¾Îì¸ ÓÊÔõ 
§ÁÖõ «¾É¡ø ²üÀÎõ ¦ºÄÅ£½ò¨¾Ôõ ¾Îì¸Ä¡õ. 
¬öÅ¢ý §¿¡ì¸õ: 
þÇõ ÅÂ¾¢ø ²üÀÎõ Àì¸Å¡¾ò¾¢ý ¸¡Ã½ò¾¢Ôõ, Å¢¨Ç×¸¨ÇÔõ §ÁÖõ «¾É¡ø 
²üÀÎõ ¬Àò¨¾Ôõ ¸ñ¼È¢ÅÐ. 
¬öÅ¢ø ÀíÌ ¦ÀÚõ ¿À÷¸Ç¢ý ±ñ½¢ì¨¸: 50  
¬ö× §Áü¦¸¡ûÙõ þ¼õ: À¢. ±Š. ƒ¢. ÁÕòÐÅÁ¨É, §¸¡ÂõÒòà÷. 
¬öÅ¢ý ÀÄý¸û: 
§¿¡ö ÅÕÓý ¾Îì¸×õ Åó¾À¢ý º¢¸¢î¨º «Ç¢ì¸×õ ¯¾×õ. 
¬öÅ¢É¡ø ²üÀÎõ «¦ºª¸Ã¢Âí¸û / Àì¸ Å¢¨Ç×¸û: Àì¸ Å¢¨Ç×¸û ±Ð×õ 
þø¨Ä. 
þó¾ ¬öÅ¢ø ¸¢¨¼ìÌõ ¾¸Åø¸û ___ ÅÕ¼í¸û À¡Ð¸¡ì¸ôÀÎõ. þ¨Å 
§¾¨ÅôÀð¼¡ø §ÅÚ ¬öÅ¢üÌõ ÀÂýÀÎò¾ôÀ¼Ä¡õ. ±ó¾ ¿¢¨ÄÂ¢Öõ ¯í¸¨Çô 
ÀüÈ¢Â ¾¸Åø¸û Â¡ÕìÌõ ¦¾Ã¢Å¢ì¸ôÀ¼Á¡ð¼¡Ð. «¨Å þÃ¸º¢ÂÁ¡¸ ¨Åì¸ôÀÎõ. 
 
þó¾ ¬öÅ¢ø Àí§¸ü¸ ´ôÒì¦¸¡ûÅ¾¡ø ±ó¾ Å¢¾Á¡É ÀÄÛõ ¯í¸ÙìÌ 
¸¢¨¼ì¸¡Ð. ±ó¾ §¿Ãò¾¢ø §ÅñÎÁ¡É¡Öõ ¬öÅ¢Ä¢ÕóÐ Å¢Ä¸¢ì¦¸¡ûÙõ ¯Ã¢¨Á 
¯í¸ÙìÌ ¯ñÎ. ¬öÅ¢Ä¢ÕóÐ Å¢Ä¸¢ì¦¸¡ûÅ¾¡ø ¯í¸ÙìÌ «Ç¢ì¸ôÀÎõ 
º¢¸¢î¨ºÂ¢ø ±ó¾ Å¢¾ Á¡üÈÓõ þÕì¸¡Ð. 
 
 þó¾ ¬Ã¡öîº¢ì¸¡¸ ¯í¸Ç¢¼õ º¢Ä §¸ûÅ¢¸û §¸ð¸ôÀÎõ / º¢Ä þÃò¾ Á¡¾¢Ã¢¸û 
«øÄÐ ¾¢Í Á¡¾¢Ã¢¸û ±Îì¸ôÀÎõ. 
 
§ÁÖõ, þó¾ ¬öÅ¢ø ÀíÌ ¦¸¡ûÅÐ ¯í¸û ¦º¡ó¾ Å¢ÕôÀõ. þ¾¢ø ±ó¾ Å¢¾ì 
¸ð¼¡ÂÓõ þø¨Ä. ¿£í¸û Å¢ÕôÀô Àð¼¡ø, þó¾ ¬öÅ¢ý ÓÊ×¸û ¯í¸ÙìÌò 
¦¾Ã¢Âô ÀÎò¾ôÀÎõ.  
 
¬öÅ¡ÇÃ¢ý ¨¸¦Â¡ôÀõ : 
§¾¾¢ :  
 
¬ö×ìÌðÀÎÀÅÃ¢ý ´ôÒ¾ø: 
¿¡ý þó¾ ¬Ã¡öîº¢Â¢ý §¿¡ì¸õ ÁüÚõ «¾ý ÀÂýÀ¡ðÊ¨Éô ÀüÈ¢ 
¦¾Ç¢Å¡¸×õ, Å¢Çì¸Á¡¸×õ ¦¾Ã¢ÂôÀÎò¾ô ÀðÎû§Çý. þó¾ ¬Ã¡öîº¢Â¢ø ÀíÌ 
¦¸¡ûÇ×õ, þó¾ ¬Ã¡öîº¢Â¢ý ÁÕòÐÅ Ã£¾¢Â¡É ÌÈ¢ôÒ¸¨Ç ÅÕõ ¸¡Äò¾¢Öõ 
¯À§Â¡¸ôÀÎò¾¢ì ¦¸¡ûÇ×õ ÓØ ÁÉÐ¼ý ºõÁ¾¢ì¸¢§Èý. 
 
¬ö×ìÌðÀÎÀÅÃ¢ý ¦ÀÂ÷, Ó¸ÅÃ¢ : 
 
¨¸¦Â¡ôÀõ : 
§¾¾¢ : 
 
¬öÅ¡ÇÃ¢ý ¦¾¡¨Ä§Àº¢ ±ñ: 8754189611 
ÁÉ¢¾ ¦¿È¢Ó¨Èì ÌØ «ÖÅÄ¸ò¾¢ý ¦¾¡¨Ä§Àº¢ ±ñ: 0422 2570170 Extn.: 5818 
 
  
  
 
 
 
 
  
 
 
 
 
 
 
 MASTER CHART 1: 
SLNO IP NO OP NO AGE SEX DLP SMOKER ALCOHOLIC DIABETES HYPERTENSION IHD OTHERS 
CLINICAL 
SIGNS CN SPEECH 
1 I14023014 O14055620 45 1 N Y Y N N N N 1 1 N 
2 I14021240 O14050720 39 1 Y Y Y N N N Y 1 1 N 
3 I15007075 O14050515 45 1 N Y Y N N N Y 1 1,2 N 
4 I14016935 O14040111 40 2 N Y N N Y N Y 2 
 
Y 
5 I14020097 O10081131 45 1 N Y Y Y Y Y N 3 2 N 
6 I14020828 O14049567 45 1 N Y Y N N N N 1,2 
 
N 
7 I14028157 O14068546 44 2 N N N N N N N 2 
 
Y 
8 I14029146 O14070542 37 1 N Y N N N N Y 1 1 Y 
9 I14027926 O14067826 42 1 Y Y N Y N N Y 1 1 Y 
10 I14024384 O14057421 38 1 Y Y Y N Y N Y 1 
 
Y 
11 I14027826 O14067618 45 1 N Y N N N N Y 1 1 Y 
12 I14021842 O14052378 38 1 Y Y Y Y Y N N 12 
 
N 
13 I14022448 O14054085 43 1 Y Y Y Y Y N N 1,2 1 N 
14 I14022885 O14055319 32 2 Y N N N Y N R 1 1 N 
15 I14025003 O14061491 44 2 Y N N N N N Y 1 
 
N 
16 I14025959 O12047986 43 1 N Y Y N Y N Y 1 1 N 
17 I14026399 O14064697 34 2 Y N N N N N N 1 1,2 Y 
18 I15001731 O15003942 45 1 Y Y Y N N N Y 1 
 
Y 
19 I15001790 O15003988 43 2 N N N N Y N N 1 1 Y 
20 I15001354 O15002877 41 1 N Y N Y N N Y 1 
 
Y 
21 I14029678 O12069010 41 1 N Y Y N N Y Y 1 
 
Y 
22 I14035213 O14077668 45 2 Y N N Y Y N Y 1 
 
Y 
23 I15003835 O15008164 39 1 N Y Y N N N N 1 
 
N 
24 I15004238 O15009237 39 2 Y N N N N Y Y 2 
 
Y 
25 I15005388 O15012108 21 1 N N N N N N Y 1 
 
N 
 MASTER CHART 2: 
SLNO IP NO OP NO AGE SEX DLP SMOKER ALCOHOLIC DIABETES HYPERTENSION IHD OTHERS 
CLINICAL 
SIGNS CN SPEECH 
26 I15004664 O09096593 32 2 Y N N N Y Y Y 1 
 
Y 
27 I15005072 O15000789 40 1 N Y Y N N N R 1,2 
 
N 
28 I15004684 O15010392 44 1 Y N N Y Y N N 2 2 N 
29 I15010881 O15023932 43 2 N N N N N N N 1 
 
N 
30 I15009338 O15020584 40 1 Y Y Y Y Y Y N 3 2 N 
31 I15009422 O15008011 45 1 Y Y Y N N N N 2 
 
N 
32 I15010478 O15023091 39 1 Y Y Y N N N Y 1 1 Y 
33 I15010659 O15023491 41 1 Y N Y N Y N N 1 
 
N 
34 I14013591 O14005098 36 1 Y N Y N N N Y,R 1 
 
Y 
35 I14017342 O14041004 40 1 Y Y Y N N Y Y 1 1 N 
36 I14017359 O14041034 27 1 N N Y N N N Y 1 1 N 
37 I15013007 O15028542 45 1 N N N Y Y N N 1 
 
N 
38 I15013724 O13022404 31 2 N N N N N N N 1 1 Y 
39 I15012975 O15018487 43 2 N N N Y N N Y 1 1 Y 
40 I15011843 O15025787 36 1 N N N N Y N N 2 
 
Y 
41 I15011247 O15024729 45 1 Y Y Y Y N N N 1 
 
N 
42 I15013023 O15028557 40 1 N Y Y N N N Y 1 
 
Y 
43 I15007755 O15015365 32 1 N Y Y N N N N 1 1 Y 
44 I15007826 O10090386 41 1 Y Y N N Y Y Y 1 1 Y 
45 I15008171 O12070416 20 2 N N N N N N Y 1,2 1 Y 
46 I14029157 O14070555 44 1 Y N Y Y Y N R 1 1 Y 
47 I15011176 O15024458 36 1 N Y N N N N N 1,3 2 N 
48 I14015373 O14035826 39 1 Y Y Y N Y N R 2 
 
Y 
49 I15006300 O15013834 45 1 Y Y Y Y N N N 2 
 
N 
50 I15007697 O15016774 32 2 N N N N N N N 1 1,2 Y 
  
MASTER CHART 3: 
SLN
O IP NO OP NO 
HYPER-
HC 
ARE
A 
SID
E 
ETIOLOG
Y 
NIHS
S 
INITIAL 
MRS 
FINAL MRS(AT 
3MONTHS) 
1 
I1402301
4 
O1405562
0 A 1 1 5 2 4 3 
2 
I1402124
0 
O1405072
0 A 1 1 1 2 3 2 
3 
I1500707
5 
O1405051
5 P 1 1 1 2 1 1 
4 
I1401693
5 
O1404011
1 A 1 2 2 1 2 2 
5 
I1402009
7 
O1008113
1 A 3 2 2 1 1 1 
6 
I1402082
8 
O1404956
7 A 1 2 1 1 3 1 
7 
I1402815
7 
O1406854
6 A 1 2 2 2 5 4 
8 
I1402914
6 
O1407054
2 P 1 1 1 2 5 3 
9 
I1402792
6 
O1406782
6 P 1 2 1 2 1 1 
10 
I1402438
4 
O1405742
1 A 1 2 1 2 5 5 
11 
I1402782
6 
O1406761
8 A 1 1 5 2 3 1 
12 
I1402184
2 
O1405237
8 A 1,3 2 1 1 2 2 
13 
I1402244
8 
O1405408
5 A 1 2 1 2 4 3 
14 
I1402288
5 
O1405531
9 A 2 1 3 1 1 0 
15 
I1402500
3 
O1406149
1 A 1 1 2 1 2 1 
16 
I1402595
9 
O1204798
6 A 1 2 2 1 2 2 
17 
I1402639
9 
O1406469
7 A 1 2 1 2 3 3 
18 
I1500173
1 
O1500394
2 A 1 2 5 4 5 2 
19 
I1500179
0 
O1500398
8 A 1 2 5 3 5 3 
20 
I1500135
4 
O1500287
7 A 1 2 5 3 5 5 
21 
I1402967
8 
O1206901
0 P 1 2 4 2 5 4 
22 
I1403521
3 
O1407766
8 A 2 2 5 3 5 3 
23 
I1500383
5 
O1500816
4 A 1 1 4 1 3 1 
24 
I1500423
8 
O1500923
7 A 1 2 4 3 5 3 
25 
I1500538
8 
O1501210
8 P 1 1 4 2 3 1 
 
 
 
 
 MASTER CHART 4: 
SLN
O IP NO OP NO 
HYPER-
HC 
ARE
A 
SID
E 
ETIOLOG
Y 
NIHS
S 
INITIAL 
MRS 
FINAL MRS(AT 
3MONTHS) 
26 
I1500466
4 
O0909659
3 A 1 2 5 4 5 6 
27 
I1500507
2 
O1500078
9 A 1 2 5 1 1 1 
28 
I1500468
4 
O1501039
2 A 1 1 1 1 4 2 
29 
I1501088
1 
O1502393
2 A 1 2 1 1 1 0 
30 
I1500933
8 
O1502058
4 A 1,3 2 3 1 3 2 
31 
I1500942
2 
O1500801
1 A 3 1 5 1 3 1 
32 
I1501047
8 
O1502309
1 A 1,3 1 5 2 5 4 
33 
I1501065
9 
O1502349
1 A 1 2 1 2 3 1 
34 
I1401359
1 
O1400509
8 A 1 2 1 3 5 5 
35 
I1401734
2 
O1404100
4 A 1 2 2 2 4 3 
36 
I1401735
9 
O1404103
4 A 1 2 2 2 5 3 
37 
I1501300
7 
O1502854
2 A 1 1 3 3 5 4 
38 
I1501372
4 
O1302240
4 A 1 2 4 3 5 5 
39 
I1501297
5 
O1501848
7 A 1 2 1 3 5 4 
40 
I1501184
3 
O1502578
7 A 3 1,2 3 2 5 4 
41 
I1501124
7 
O1502472
9 A 1 1 1 2 5 4 
42 
I1501302
3 
O1502855
7 P 1 2 1 3 5 5 
43 
I1500775
5 
O1501536
5 P 1 1 1 2 4 3 
44 
I1500782
6 
O1009038
6 A 1 1 1 1 2 1 
45 
I1500817
1 
O1207041
6 A 1 2 4 1 2 0 
46 
I1402915
7 
O1407055
5 A 1 1 1 2 5 4 
47 
I1501117
6 
O1502445
8 A 1 2 2 1 1 0 
48 
I1401537
3 
O1403582
6 A 1 2 1 2 2 1 
49 
I1500630
0 
O1501383
4 P 3 1 4 1 1 0 
50 
I1500769
7 
O1501677
4 A 1 1 5 3 3 2 
 
 
 
 
 
 MASTER KEY CHART 1 AND 2 
SEX – 
1 - MALE 
2 - FEMALE 
Y=YES 
N=NO 
CLINICAL SIGNS: 
1 - WEAKNESS 
2 - GIDDINESS 
3 - BLURRING 
CRANIAL NERVES (CN): 
1 - SEVENTH CRANIAL NERVE 
2 - OTHER CRANIAL NERVES 
DLP - DYSLIPIDEMIA 
 
 
  
 CHART 3 AND 4: 
HYPERHOMOCYSTINEMIA 
P=PRESENT 
A=ABSENT 
AREA- 
1 - MCA 
2 - ACA 
3 - PCA 
SIDE 
1 - RIGHT 
2 - LEFT  
ETIOLOGY 
1 - ATHEROSCLEROSIS 
2 - CARDIOEMBOLIC 
3 - LACUNAR INFARCT 
4 - OTHER ETIOLOGY 
5 - UNKNOWN ETIOLOGY 
NIHSS 
1 – 0-4 
2 – 5-15 
3 – 16-20 
4 – 21-42 
